Data / Research funding / Atherosclerosis
Atherosclerosis: 1,254 NIH awards ($1.8B) to 233 organizations
1,254 NIH awards ($1.8B) in the NIH spending category Atherosclerosis, to 233 organizations, read 2026-11-03. NIH fiscal years 2021 to 2025.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- Topic
- NIH spending category
Awards
The 500 largest of 1,254 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Comparison of Anti-coagulation and anti-Platelet Therapies for Intracranial Vascular Atherostenosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $26,536,563 | September 1, 2021 | May 31, 2028 | HOH, BRIAN LIM | reporter.nih.gov |
| Subclinical Vascular Contributions to Alzheimer's Disease: The Multi-Ethnic Study of Atherosclerosis (MESA) Multisite Study of AD (Renewal) | NIH | National Institute on Aging | 2021 to 2025 | $17,112,209 | August 15, 2018 | May 31, 2029 | HUGHES, TIMOTHY M. | reporter.nih.gov |
| Carotid Revascularization and Medical Management for Asymptomatic Carotid Stenosis Trial (CREST-2) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $16,136,344 | March 15, 2014 | August 31, 2026 | BROTT, THOMAS G | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) FIELD CENTER (FC) - TASK AREA D | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $14,739,138 | August 13, 2023 | August 12, 2025 | CARSON, APRIL | reporter.nih.gov |
| MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), COORDINATING CENTER - TASK AREA A - CORE STUDY OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $14,440,476 | December 19, 2024 | April 11, 2025 | MCCLELLAND, ROBYN LEAGH | reporter.nih.gov |
| 1/2 REPRIEVE Extension for Trial Completion | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $14,219,228 | May 1, 2023 | April 30, 2027 | GRINSPOON, STEVEN K. | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) COORDINATING CENTER (CC) - TASK AREA D | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $13,919,988 | August 13, 2023 | August 12, 2025 | CARSON, APRIL | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - COORDINATING CENTER - TASK AREA B.2 AND B.3 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $13,712,636 | November 15, 2024 | September 30, 2025 | COUPER, DAVID | reporter.nih.gov |
| Testing Hypothesized Pathways Linking Infection, Physical Activity, Apoe Genotype, And Biological Sex To Low Dementia Prevalence And Reduced Brain Atrophy In Two Native American Populations | NIH | National Institute on Aging | 2022 to 2025 | $12,690,286 | April 15, 2017 | April 30, 2027 | KAPLAN, HILLARD S | reporter.nih.gov |
| The International Study of Comparative Health Effectiveness with Medical and Invasive Approaches (ISCHEMIA) trial EXTENDed Follow-up (EXTEND) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $10,079,314 | April 1, 2021 | March 31, 2027 | HOCHMAN, JUDITH S | reporter.nih.gov |
| Immune Cell Interactions in Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $9,386,571 | August 1, 2017 | May 31, 2027 | HEDRICK, CATHERINE C | reporter.nih.gov |
| Coronary Artery Calcium and its Association with Protective/Risk Factors and Epigenetic Patterns in Diverse US Hispanic/Latino Adults | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $8,752,600 | June 1, 2021 | May 31, 2026 | DAVIGLUS, MARTHA L | reporter.nih.gov |
| Atherosclerosis Intervention with Novel Tissue Selective Estrogen Complex Therapy | NIH | National Institute on Aging | 2021 to 2023 | $8,410,475 | March 1, 2019 | August 31, 2025 | HODIS, HOWARD NEIL | reporter.nih.gov |
| Coronary Artery Calcium in the PRagmatic EValuation of evENTs And Benefits of Lipid lowering in the Elderly: CAC PREVENTABLE Ancillary Study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $7,505,536 | September 1, 2021 | July 31, 2027 | DAUBERT, MELISSA | reporter.nih.gov |
| Biogenesis and Catabolism of Atherogenic Lipoproteins | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $7,418,574 | May 1, 2023 | April 30, 2028 | HUSSAIN, M MAHMOOD | reporter.nih.gov |
| Leveraging the 24-hour movement paradigm to preserve cognitive function and prevent Alzheimer's disease: The Multi-Ethnic Study of Atherosclerosis (MESA) 24H-ACT Study | NIH | National Institute on Aging | 2021 to 2024 | $7,263,372 | May 1, 2021 | April 30, 2026 | DIAZ, KEITH M | reporter.nih.gov |
| New approaches for understanding lipid movement in health and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $6,999,930 | May 1, 2019 | April 30, 2025 | YOUNG, STEPHEN G. | reporter.nih.gov |
| Precision phenotyping of emphysema in the elderly: the MESA Lung Study | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $6,794,185 | August 2, 2004 | January 31, 2027 | BARR, R GRAHAM | reporter.nih.gov |
| Extracranial Carotid Atherosclerosis Contributions to Cognitive Impairment and Alzheimer's Disease Risk | NIH | National Institute on Aging | 2021 to 2025 | $6,475,434 | August 15, 2021 | May 31, 2027 | WEINKAUF, CRAIG C | reporter.nih.gov |
| Contributions of stress reactivity to risk of Alzheimer's disease and related dementia's in a community-based cohort | NIH | National Institute on Aging | 2021 to 2025 | $6,416,931 | September 30, 2021 | May 31, 2027 | KERSHAW, KIARRI N | reporter.nih.gov |
| Multi-Center Implementation and Validation of Efficient Magnetic Resonance Imaging and Analysis of Atherosclerotic Disease of the Cervical Carotid | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,132,273 | September 1, 2021 | August 31, 2027 | PARKER, DENNIS L | reporter.nih.gov |
| Metabolic effects and mechanisms for heart failure in South Asians | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $6,092,913 | June 7, 2021 | May 31, 2027 | KANAYA, ALKA M. | reporter.nih.gov |
| Effects of HIV, Cocaine, and Prolonged ART Use on Subclinical Cardiovascular Disease | NIH | National Institute on Drug Abuse | 2021 to 2024 | $5,744,264 | June 1, 2016 | April 30, 2025 | LAI, SHENGHAN | reporter.nih.gov |
| Hyperglycemia and Adverse Pregnancy Outcome Study-Cardiovascular Health of HAPO Offspring (HAPO CVH) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $5,660,048 | March 1, 2023 | February 29, 2028 | BRICKMAN, WENDY J | reporter.nih.gov |
| CREST-2 Statistical and Data Coordinating Center - SDCC | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $5,657,860 | March 15, 2014 | August 31, 2026 | EDWARDS, LLOYD J | reporter.nih.gov |
| Interplay of Myocardial Fibrosis and Cardiac TTR Amyloid in Age Related Cardiac Remodeling in MESA-Multi-Ethnic Study of Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,552,808 | April 1, 2022 | March 31, 2027 | LIMA, JOAO A C | reporter.nih.gov |
| Cellular Decision Making | NIH | National Institute of General Medical Sciences | 2021 to 2025 | $5,164,037 | June 1, 2016 | May 31, 2026 | WEINER, ORION D | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) UNDERGRADUATE TRAINING AND EDUCATION CENTER (UTEC) - TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $5,146,731 | August 13, 2023 | August 12, 2025 | WHITE, WENDY | reporter.nih.gov |
| Identifying new strategies for prevention of cardiovascular complications of diabetes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $5,112,534 | May 1, 2020 | April 30, 2026 | BORNFELDT, KARIN E | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER, TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $5,086,390 | November 15, 2021 | March 14, 2026 | LUTSEY, PAMELA L. | reporter.nih.gov |
| Novel vascular smooth muscle cell progenitors in development and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,999,830 | July 1, 2020 | June 30, 2027 | GREIF, DANIEL | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER, TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,994,412 | November 15, 2021 | February 19, 2026 | WAGENKNECHT, LYNNE E | reporter.nih.gov |
| Contribution of Longitudinal Neighborhood Determinants to Cognitive Health and Dementia Disparities within a Multi-Ethnic Cohort | NIH | National Institute on Aging | 2021 to 2025 | $4,930,675 | May 15, 2021 | February 28, 2027 | HIRSCH, JANA ARIEL | reporter.nih.gov |
| IgE antibody responses to the oligosaccharide galactose-alpha-1,3-galactose (alpha-gal) in murine and human atherosclerosis | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2025 | $4,866,733 | July 1, 2022 | June 30, 2027 | ERICKSON, LOREN D | reporter.nih.gov |
| A Mechanistic and Translational Research Program Linking Impaired Resolution, Defective Efferocytosis, and Clonal Hematopoiesis to the Formation of Clinically Dangerous Atherosclerotic Plaques | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,837,260 | March 7, 2019 | February 28, 2026 | TABAS, IRA A | reporter.nih.gov |
| Vasculo-neuronal pathophysiological interface in Alzheimer’s and Atherosclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2024 | $4,815,513 | September 18, 2024 | August 31, 2027 | IRUELA-ARISPE, M. LUISA | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER, TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,813,353 | January 15, 2025 | January 14, 2026 | WINDHAM, BEVERLY GWEN | reporter.nih.gov |
| THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - FIELD CENTER | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,714,816 | January 1, 2025 | December 31, 2025 | ARGANI, PEDRAM | reporter.nih.gov |
| Insights into the molecular mechanisms regulating vascular and immune metabolism in vascular diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,709,849 | January 15, 2021 | December 31, 2027 | SUAREZ, YAJAIRA | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) GRADUATE TRAINING AND EDUCATION CENTER (GTEC) - TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $4,701,181 | August 13, 2023 | August 12, 2025 | PAYTON, MARINELLE | reporter.nih.gov |
| PRE-DETERMINE: Advancing Sudden Arrhythmic Death Prediction in Coronary Artery Disease in the Absence of Severe Systolic Dysfunction | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $4,550,671 | February 15, 2023 | January 31, 2027 | ALBERT, CHRISTINE M | reporter.nih.gov |
| Contemporary Classification of Myocardial Injury Events in MESA: Defining Distinct Risk Factor Associations with Myocardial Infarction Type 1-5 and Acute Non-Ischemic Myocardial Injury | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,444,163 | August 20, 2021 | July 31, 2027 | DEFILIPPIS, ANDREW | reporter.nih.gov |
| MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), FIELD CENTER (FC): TASK AREA A - CORE OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,339,742 | December 19, 2024 | April 11, 2025 | WATSON, KAROL E | reporter.nih.gov |
| Mechanisms of Platelet Activity in Vascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,269,155 | February 15, 2019 | January 31, 2027 | BERGER, JEFFREY S | reporter.nih.gov |
| Systems Biology Analyses for Hemodynamic Regulation of Vascular Homeostasis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $4,086,050 | August 24, 2012 | July 31, 2025 | SHYY, JOHN YJ | reporter.nih.gov |
| Low-Profile 3D-Printed Radiopaque Bioresorbable Vascular Scaffolds | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $4,062,443 | January 1, 2019 | April 30, 2028 | AMEER, GUILLERMO ANTONIO | reporter.nih.gov |
| Patient-specific Outcome Prediction from Cardiovascular Multimodality Imaging by Artificial Intelligence | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,034,369 | June 1, 2022 | May 31, 2029 | SLOMKA, PIOTR J | reporter.nih.gov |
| Immune checkpoint inhibitors and accelerated coronary atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $4,014,114 | May 1, 2022 | April 30, 2027 | NEILAN, TOMAS G | reporter.nih.gov |
| Harnessing Artificial Intelligence and Deep Learning to Determine a Coronary Artery Calcium Estimate in Patients with No History of AtheroSclerotic CardioVascular Disease (HIDDEN-ASCVD) Study | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,918,561 | September 27, 2025 | August 31, 2029 | AMBROSY, ANDREW PATRICK | reporter.nih.gov |
| 1/2 PREEMPT: Prospective RandomizEd Evaluation and Management of Premature aTherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,886,403 | July 30, 2025 | June 30, 2027 | PAGIDIPATI, NEHA JADEJA | reporter.nih.gov |
| Community Health Worker-Led Church-Based Intervention for Eliminating Cardiovascular Health Disparities in African Americans | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,868,770 | September 10, 2020 | August 31, 2027 | MILLS, KATHERINE TERESA | reporter.nih.gov |
| Understanding health disparities in Pakistani, Bangladeshi and Asian Indian immigrants: the role of socio-cultural context, acculturation and resilience resources | NIH | National Institute on Minority Health and Health Disparities | 2021 to 2025 | $3,855,804 | July 2, 2021 | March 31, 2027 | KANAYA, ALKA M. | reporter.nih.gov |
| MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), FIELD CENTER (FC): TASK AREA A - CORE OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,838,691 | December 19, 2024 | April 11, 2025 | SIEGEL, JONATHAN H | reporter.nih.gov |
| Jackson Heart Study (JHS) Field Center | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,819,327 | September 15, 2025 | September 14, 2026 | reporter.nih.gov | |
| Catheter for Complex Percutaneous Coronary Intervention | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,814,040 | July 20, 2020 | January 31, 2027 | FISCHELL, TIM ALEXANDER | reporter.nih.gov |
| Jackson Heart Study (JHS) Coordinating Center: Task Area A - Core Study Operations | NIH | National Heart, Lung, and Blood Institute | 2025 | $3,791,131 | September 15, 2025 | September 14, 2035 | reporter.nih.gov | |
| Long-Term Observational Extension of Participants in the CREST-2 Randomized Clinical Trial | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,784,947 | September 1, 2021 | August 31, 2026 | MESCHIA, JAMES F | reporter.nih.gov |
| Managing Atherosclerosis by Modulating HDL Function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,778,414 | June 1, 2013 | March 31, 2026 | GHADIRI, M. REZA | reporter.nih.gov |
| MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), FIELD CENTER (FC): TASK AREA A - CORE OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,739,546 | December 19, 2024 | April 11, 2025 | PANKOW, JAMES S | reporter.nih.gov |
| Rational Integration of Polygenic Risk Scores (RIPS) | NIH | National Human Genome Research Institute | 2022 to 2025 | $3,737,256 | March 10, 2022 | February 28, 2027 | PETERSON, JOSEPH F. | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) GRADUATE TRAINING AND EDUCATION CENTER (GTEC) - TASK AREA B | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,682,352 | August 13, 2023 | August 12, 2025 | RENEKER, JENNIFER | reporter.nih.gov |
| Clock modulation in circadian desynchrony induced diabetes and atherovascular disease - mechanisms and interventions | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,665,703 | July 20, 2021 | April 30, 2027 | YECHOOR, VIJAY K | reporter.nih.gov |
| Targeted Molecular Probes for Atherosclerosis Imaging and Therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,625,326 | February 15, 2019 | January 31, 2027 | LIU, YONGJIAN | reporter.nih.gov |
| Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) accelerates atherosclerotic plaque progression | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,595,504 | February 1, 2022 | June 30, 2026 | SHAW, LESLEE J | reporter.nih.gov |
| Circulating levels of Persistent Organic Pollutants and Subclinical Atherosclerosis progression in Postmenopausal women | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $3,506,220 | September 20, 2022 | July 31, 2027 | KARIM, ROKSANA | reporter.nih.gov |
| Optimize Risk Assessment for Incident and Recurrent Atherosclerotic Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,484,566 | July 15, 2021 | June 30, 2027 | ZHANG, YIYI | reporter.nih.gov |
| Enhancing the public health benefits of mammography screening by informing women of both breast cancer and breast arterial calcification results: A randomized trial to promote cardiovascular health | NIH | National Cancer Institute | 2021 to 2025 | $3,435,650 | April 1, 2022 | March 31, 2027 | MONTGOMERY, GUY H | reporter.nih.gov |
| Dual-modality FLIm and PSOCT for intravascular imaging of plaque in patients | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,431,403 | September 10, 2021 | August 31, 2026 | MARCU, LAURA | reporter.nih.gov |
| Clonal expansion, resistance to efferocytosis and innate immunity in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,398,319 | January 15, 2019 | December 31, 2024 | LEEPER, NICHOLAS JAMES | reporter.nih.gov |
| Randomized comparison of the clinical Outcome of single versus Multiple Arterial grafts: Quality of Life (ROMA:QOL) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,332,837 | April 21, 2020 | March 31, 2026 | GAUDINO, MARIO FL | reporter.nih.gov |
| Molecular Regulation of Atherosclerosis Regression - Renewal | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,330,002 | April 1, 2006 | February 28, 2026 | FISHER, EDWARD A | reporter.nih.gov |
| Endothelial-to-mesenchymal transition and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,325,689 | January 12, 2017 | December 31, 2024 | SCHWARTZ, MARTIN A | reporter.nih.gov |
| Using genetic variation to study biology of blood lipids & coronary heart disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,324,792 | April 1, 2015 | June 30, 2026 | PELOSO, GINA MARIE | reporter.nih.gov |
| Apolipoprotein C3-loading of apolipoprotein B100 lipoproteins and cardiovascular disease in patients with type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,318,186 | January 5, 2022 | December 31, 2026 | HEINECKE, JAY W | reporter.nih.gov |
| Vascular smooth muscle cell heterogeneity and disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,305,617 | March 1, 2021 | December 31, 2025 | SIMONS, MICHAEL | reporter.nih.gov |
| Assessment of Mast Cell Degranulation in Infarcted Myocardium Using Quantitative Multiparametric MRI | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,298,936 | July 1, 2022 | June 30, 2027 | LI, DEBIAO | reporter.nih.gov |
| JACKSON HEART STUDY (JHS) COMMUNITY ENGAGEMENT CENTER - TASK AREA B: DEMONSTRATION PROJECTS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,272,668 | September 25, 2023 | September 24, 2024 | SUTTON, VICTOR D | reporter.nih.gov |
| The role of macrophages in weight loss-induced metabolic health and adipose tissue inflammation resolution | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $3,255,832 | September 20, 2025 | September 19, 2029 | WEINSTOCK, ADA | reporter.nih.gov |
| PET Imaging of Thrombus | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,247,850 | August 1, 2011 | January 31, 2027 | CARAVAN, PETER D | reporter.nih.gov |
| Role of inflammation in intraplaque hemorrhage pathogenesis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,239,521 | May 1, 2022 | April 30, 2027 | KIM, FRANCIS | reporter.nih.gov |
| Critical Mediators of Inflammation Resolution and Immune Memory in Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,233,358 | July 1, 2021 | June 30, 2027 | DORAN, AMANDA C | reporter.nih.gov |
| MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), FIELD CENTER (FC): TASK A - CORE OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,230,987 | December 19, 2024 | April 11, 2025 | POST, WENDY S | reporter.nih.gov |
| Role of Monoamine Oxidase A and Diet-Induced Monocyte Dysfunction, Macrophage Reprogramming, and Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,224,599 | April 20, 2021 | March 31, 2027 | ASMIS, RETO H.R. | reporter.nih.gov |
| Precision nanomedicine targeting novel endothelial mechano-sensing mechanisms | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,222,128 | June 1, 2022 | May 31, 2029 | FANG, YUN | reporter.nih.gov |
| The epigenetic regulation of inflammation in tissue repair and vascular disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,217,378 | July 1, 2023 | June 30, 2030 | GALLAGHER, KATHERINE ANN | reporter.nih.gov |
| Early myocardial remodeling and progressive kidney function decline in type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,199,007 | December 24, 2021 | November 30, 2026 | DORIA, ALESSANDRO | reporter.nih.gov |
| Clonal Hematopoeisis of Indeterminate Potential and Risk of Autopsy-defined Sudden Cardiac Death | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,193,873 | December 1, 2021 | November 30, 2026 | TSENG, ZIAN H | reporter.nih.gov |
| Early Developmental Risk for Adult Cardiovascular Disease: High risk Subgroups, Biomarkers, and Mechanisms | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $3,193,149 | August 1, 2024 | May 31, 2028 | BUKA, STEPHEN L | reporter.nih.gov |
| Characterization of cardiovascular diseases (CVD) in people with long duration Type 1 diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,160,264 | December 24, 2021 | November 30, 2025 | KING, GEORGE L | reporter.nih.gov |
| Endothelial Cell to Mesenchymal Cell Transitions Play a Critical Biological Sex- and Aging-Dependent Role in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,155,829 | January 1, 2022 | December 31, 2025 | OWENS, GARY K | reporter.nih.gov |
| Carotid Revascularization and Medical Management for Asymptomatic CarotidStenosis Trial - Hemodynamics (CREST-H) | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $3,153,445 | May 15, 2017 | July 31, 2027 | MARSHALL, RANDOLPH S | reporter.nih.gov |
| Preclinical Assessment of a Compliance Matched Biopolymer Vascular Graft | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,139,611 | December 15, 2021 | November 30, 2026 | VANDE GEEST, JONATHAN PIETER | reporter.nih.gov |
| Mechanisms of atherosclerotic cardiovascular complications | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,139,538 | September 1, 2022 | August 31, 2026 | GIANNARELLI, CHIARA | reporter.nih.gov |
| The role of signaling adaptor protein epsin in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,138,613 | December 15, 2020 | November 30, 2025 | CHEN, HONG | reporter.nih.gov |
| High-throughput investigation of human genetic variants affecting cholesterol uptake and efflux | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,136,707 | July 1, 2022 | June 30, 2026 | SHERWOOD, RICHARD I | reporter.nih.gov |
| Mental Stress Reactivity in Women with Coronary Microvascular Dysfunction | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,125,714 | January 1, 2022 | April 29, 2025 | MEHTA, PUJA KIRAN | reporter.nih.gov |
| An evaluation of insomnia treatment to reduce cardiovascular risk in patients with posttraumatic stress disorder | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,107,795 | July 1, 2020 | June 30, 2026 | BECKHAM, JEAN C. | reporter.nih.gov |
| Cardiovascular risk from comprehensive evaluation of the CT calcium score exam | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $3,104,134 | March 15, 2023 | February 28, 2027 | WILSON, DAVID LYNN | reporter.nih.gov |
| Development, testing, and implementation of virtual statin associated muscle symptom (SAMS) management | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,101,192 | August 20, 2021 | May 31, 2027 | KING, JORDAN BRADLEY | reporter.nih.gov |
| Psychological symptoms in healthcare workers following the COVID-19 pandemic and relationship to long-term cardiovascular risk | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,099,293 | February 1, 2022 | January 31, 2027 | CHANG, BERNARD P. | reporter.nih.gov |
| Aspirin-triggered Specialized Pro-resolving Mediators in Increasing Weight and Atherosclerotic Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,089,508 | April 1, 2021 | March 31, 2027 | HEFFRON, SEAN PATRICK | reporter.nih.gov |
| Community Health Worker-Led Church-Based Intervention for Eliminating Cardiovascular Health Disparities in African Americans | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $3,081,890 | September 10, 2020 | August 31, 2023 | HE, JIANG | reporter.nih.gov |
| Pathways of Tissue Lipid Uptake | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,060,403 | April 1, 1991 | November 30, 2025 | GOLDBERG, IRA J | reporter.nih.gov |
| The Gut Microbiota in Metabolic Surgery: A Multi-Ethnic, Multi-Omic, Longitudinal Study | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $3,059,645 | February 5, 2021 | January 31, 2027 | YU, DANXIA | reporter.nih.gov |
| Causal variant association mechanisms in TCF21 binding coronary disease loci | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,054,012 | January 1, 2017 | November 30, 2028 | QUERTERMOUS, THOMAS | reporter.nih.gov |
| Non-coding RNA regulation of cholesterol homeostasis and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,051,000 | March 1, 2017 | February 29, 2024 | MOORE, KATHRYN J | reporter.nih.gov |
| Quantitative model-based ESUS reclassification using cardiac and cerebral vessel wall MRI | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $3,048,621 | September 21, 2022 | August 31, 2027 | YUAN, CHUN | reporter.nih.gov |
| Reducing Arterial Inflammation and Improving Metabolic Health by Dual CCR2 and CCR5 Antagonism in People Living with HIV | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,045,572 | September 5, 2020 | August 31, 2025 | LO, JANET | reporter.nih.gov |
| MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA), FIELD CENTER (FC): TASK AREA A - CORE OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $3,040,735 | December 19, 2024 | April 11, 2025 | BERTONI, ALAIN GERALD | reporter.nih.gov |
| The Role of Adaptor Protein Disabled-2 in Maintaining Endothelial Cell Function in Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,039,522 | December 1, 2021 | November 30, 2026 | CHEN, HONG | reporter.nih.gov |
| Enhancing parasympathetic activity to reduce vascular oxidative stress and endothelial dysfunction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,026,236 | June 1, 2021 | May 31, 2026 | SHIBAO, CYNDYA ADRIANA | reporter.nih.gov |
| Targeting Pyruvate Kinase M2: A novel strategy to combat thrombo-inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,020,183 | April 1, 2018 | March 31, 2025 | CHAUHAN, ANIL KUMAR | reporter.nih.gov |
| Atherosclerosis in cocaine addiction: imaging risk with PET/MR | NIH | National Institute on Drug Abuse | 2022 to 2025 | $3,015,410 | June 1, 2022 | March 31, 2027 | ALIA-KLEIN, NELLY | reporter.nih.gov |
| The identification and pathophysiology of non-infarcted but injured myocardium in the post-ischemic heart | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,015,015 | January 1, 2021 | December 31, 2025 | ZHAO, MING | reporter.nih.gov |
| The Identification and characterization of genetic variants underlying cardiovascular diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $3,015,000 | January 23, 2017 | December 31, 2023 | MANI, ARYA | reporter.nih.gov |
| Genome-wide association study of coronary artery disease in individuals of African ancestry | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,009,772 | August 1, 2021 | July 31, 2025 | LU, YINGCHANG | reporter.nih.gov |
| Effect of reproductive history on longitudinal change in cardiac, vascular and lipid parameters | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $3,007,759 | December 1, 2021 | November 30, 2026 | WOO, JESSICA G | reporter.nih.gov |
| Whole-genome sequencing analysis of coronary atherosclerosis and related traits | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $3,003,154 | March 17, 2020 | February 28, 2026 | DE VRIES, PAUL STEFAN | reporter.nih.gov |
| Molecular Mechanisms Governing Vascular Cell Function and Phenotype in Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,993,449 | April 1, 2021 | March 31, 2026 | CHEN, HONG | reporter.nih.gov |
| Clinical translation of targeted intracoronary imaging for inflammatory activity | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,992,135 | July 22, 2022 | June 30, 2027 | TEARNEY, GUILLERMO J | reporter.nih.gov |
| Identification Methods, Patient Activation, and Cascade Testing for FH: IMPACT-FH | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,991,274 | August 15, 2019 | July 31, 2028 | MORALES REYES, ANA | reporter.nih.gov |
| EOI::DEFEND THE SPEND::EOI NOTICE OF TERMINATION FOR CONVENIENCE | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,981,331 | December 19, 2024 | April 11, 2025 | SHEA, STEVEN J | reporter.nih.gov |
| Super Resolution Ultrasound Imaging of Vasa Vasorum to Characterize the Progression of Atherosclerotic Plaques and Predict Rupture Vulnerability | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,981,035 | February 1, 2022 | January 31, 2027 | KIM, KANG | reporter.nih.gov |
| PET Detection of CCR2 in Human Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,962,141 | February 1, 2020 | January 31, 2026 | GROPLER, ROBERT J. | reporter.nih.gov |
| Improving Risk Stratification in Familial Hypercholesterolemia (RISK-FH) | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,954,136 | July 1, 2022 | June 30, 2027 | OETJENS, MATTHEW | reporter.nih.gov |
| Comprehensive functional genomic analysis of the multi-disease associated CDKN2A/B locus | NIH | National Institute on Aging | 2021 to 2025 | $2,949,687 | September 30, 2021 | June 30, 2027 | LI, GANG | reporter.nih.gov |
| Epidemiology of Venous Thrombosis and Pulmonary Embolism | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,941,493 | February 1, 1998 | February 28, 2026 | TANG, WEIHONG | reporter.nih.gov |
| Clonal hematopoiesis, inflammasomes and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,941,081 | February 15, 2021 | January 31, 2029 | TALL, ALAN RICHARD | reporter.nih.gov |
| Air pollutant exposure and progression of subclinical atherosclerosis during the critical transition from childhood to adulthood | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $2,923,915 | December 16, 2020 | October 31, 2026 | FARZAN, SHOHREH F | reporter.nih.gov |
| Role of Metabolic Reprogramming in Formation and Maintenance of the Acta2+ Atherosclerotic Lesion Protective Fibrous Cap | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,900,593 | July 1, 2021 | June 30, 2025 | OWENS, GARY K | reporter.nih.gov |
| Atheroprotection by smooth muscle selective RhoGAPs | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,891,948 | August 1, 2022 | July 31, 2027 | TAYLOR, JOAN M | reporter.nih.gov |
| Integrating Artificial Intelligence for Optimal Analysis of CardiacPET/CT | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,885,687 | September 22, 2022 | June 30, 2027 | SLOMKA, PIOTR J | reporter.nih.gov |
| Genetic Repair of Familial Hypercholesterolemia | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,883,128 | December 20, 2016 | March 31, 2027 | LAGOR, WILLIAM RAYMOND | reporter.nih.gov |
| Obstructive sleep apnea, the microbiome and cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,867,397 | January 1, 2022 | December 31, 2025 | HADDAD, GABRIEL G | reporter.nih.gov |
| Nitro-Fatty Acids and Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,867,343 | August 1, 2022 | June 30, 2027 | CHEN, YUQING EUGENE | reporter.nih.gov |
| Clonal hematopoiesis in humans: determinants of development and progression | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $2,867,247 | July 19, 2019 | March 31, 2025 | BALLANTYNE, CHRISTIE MITCHELL | reporter.nih.gov |
| Elucidating the Molecular Mechanisms Underlying LYST-mediated Tissue Engineered Vascular Graft Stenosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,861,908 | April 1, 2021 | March 31, 2026 | BREUER, CHRISTOPHER KANE | reporter.nih.gov |
| Phenotyping Genetic Disorders of Hepatic Lipid and Lipoprotein Metabolism in Cells, Mice, and Men | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,861,646 | January 1, 2017 | December 31, 2024 | GINSBERG, HENRY N | reporter.nih.gov |
| Cholesterol efflux, CHIP and inflammasome activation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,851,266 | June 1, 2011 | May 31, 2027 | TALL, ALAN RICHARD | reporter.nih.gov |
| Multi Site Randomized Trial of a GLP-1/GIP Receptor Agonist for Smoking Cessation | NIH | National Institute on Drug Abuse | 2025 | $2,828,440 | July 15, 2025 | March 31, 2028 | HENDERSHOT, CHRISTIAN S | reporter.nih.gov |
| Plaque and blood derived macrophages: a multi-omic assessment of CVD pathogenesis in PLWH | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,820,394 | September 15, 2021 | August 31, 2025 | FUNDERBURG, NICHOLAS T. | reporter.nih.gov |
| Dissecting Causal Role of Insomnia in Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,815,857 | May 15, 2020 | April 30, 2025 | SAXENA, RICHA | reporter.nih.gov |
| Development of gene editing based therapy for cardiovascular diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,813,308 | July 1, 2021 | June 30, 2025 | CHEN, YUQING EUGENE | reporter.nih.gov |
| Cholesterol Regulation of Endothelial K+ Channels | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,807,731 | April 1, 2004 | May 31, 2026 | LEVITAN, IRENA | reporter.nih.gov |
| Shear Stress and Endothelial Pathophysiology in Intracranial Atherosclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2025 | $2,803,513 | February 1, 2020 | October 31, 2025 | LIEBESKIND, DAVID SIGMUND | reporter.nih.gov |
| A Receptor-Targeted Nanoparticle PET Tracer in Human Carotid Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,801,867 | August 1, 2022 | May 31, 2027 | WOODARD, PAMELA K | reporter.nih.gov |
| Mechanisms of vascular and valvular calcification | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,799,000 | January 1, 2018 | December 31, 2023 | GIACHELLI, CECILIA M | reporter.nih.gov |
| Characterization of Coagulation Factor-platelet Interactions: Role of FXI | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,797,266 | July 15, 2010 | April 30, 2028 | MCCARTY, OWEN J | reporter.nih.gov |
| AIBP therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,790,000 | February 1, 2017 | January 31, 2024 | MILLER, YURY | reporter.nih.gov |
| Elastic, Degradable Vascular Grafts with Helical Microfibers | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,787,042 | August 15, 2021 | July 31, 2025 | WANG, YADONG | reporter.nih.gov |
| Trans-omic analysis of epicardial adipose tissue in atrial fibrillation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,783,046 | February 1, 2021 | January 31, 2026 | GOLDBERGER, JEFFREY J | reporter.nih.gov |
| Mechanosensitive M7G epitranscriptome in endothelial health and disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,773,984 | December 22, 2021 | November 30, 2026 | HE, CHUAN | reporter.nih.gov |
| Personalized lesion modification optimizes atherosclerosis intervention | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,767,637 | January 1, 2022 | December 31, 2025 | EDELMAN, ELAZER R | reporter.nih.gov |
| Gut Flora metabolism of dietary carnitine and cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,763,113 | August 1, 2010 | April 30, 2026 | HAZEN, STANLEY L | reporter.nih.gov |
| RNA-Binding Proteins in the Regulation of Vascular Inflammation and Immunity | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,748,765 | February 15, 2021 | January 31, 2027 | MURPHY, PATRICK ANDRIES | reporter.nih.gov |
| Long-Acting RNAi Therapy for Atherosclerosis and Insulin Resistance | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,745,822 | July 1, 2021 | June 30, 2026 | SHI, JINJUN | reporter.nih.gov |
| Computational model-driven design to mitigate vein graft failure after coronary artery bypass | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,736,546 | August 15, 2022 | June 30, 2027 | MARSDEN, ALISON L | reporter.nih.gov |
| Novel Targets for Reducing Atherosclerosis in Type 1 Diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,734,575 | December 1, 2021 | November 30, 2026 | BIDDINGER, SUDHA B | reporter.nih.gov |
| Metal Exposure and Early Cardiovascular Risk in Adult E-Cigarette Users | NIH | National Institute of Environmental Health Sciences | 2021 to 2024 | $2,730,969 | August 1, 2020 | May 31, 2026 | NAVAS-ACIEN, ANA | reporter.nih.gov |
| Pathogenesis of Dyslipidemia and Atherosclerosis in the Diabetic State | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,729,452 | September 1, 2011 | June 30, 2025 | BIDDINGER, SUDHA B | reporter.nih.gov |
| Aromatic Amino Acids, Microbiome-Generated Metabolites, and Incident Subclinical and Clinical CVD and Mortality | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,706,539 | July 1, 2017 | January 31, 2028 | MOZAFFARIAN, DARIUSH | reporter.nih.gov |
| Renal Therapeutic Angiogenesis Using the Novel Biologic ELP-VEGF | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2024 | $2,693,585 | April 1, 2017 | August 31, 2025 | BIDWELL, GENE LEFLORE | reporter.nih.gov |
| PDGFD regulates a transcriptional network to modulate smooth muscle cell transition and coronary artery disease risk | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,687,815 | April 15, 2021 | March 31, 2026 | QUERTERMOUS, THOMAS | reporter.nih.gov |
| AMPK Regulation of ACE2 in Endothelial Health and Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,666,121 | February 15, 2022 | January 31, 2026 | SHYY, JOHN YJ | reporter.nih.gov |
| Dissecting the role of CD8+ T cells in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,662,899 | August 20, 2020 | May 31, 2025 | GIANNARELLI, CHIARA | reporter.nih.gov |
| Identifying tobacco-genetic interactions through study of the aryl hydrocarbon receptor pathway. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,657,964 | April 1, 2021 | March 31, 2026 | QUERTERMOUS, THOMAS | reporter.nih.gov |
| HEG1 in endothelial function and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,657,333 | July 1, 2021 | June 30, 2025 | JO, HANJOONG | reporter.nih.gov |
| Multimodal genetic regulatory architecture of coronary artery disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,653,823 | June 1, 2019 | June 30, 2028 | MILLER, CLINT L | reporter.nih.gov |
| Quantitative Susceptibility Mapping for Stroke Risk Prediction of Vulnerable Carotid Plaques | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,652,752 | April 15, 2022 | March 31, 2027 | NGUYEN, THANH D | reporter.nih.gov |
| Dual action nanomatrix coated stent evaluation using engineered artery sheets with atherosclerotic features | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,626,329 | April 1, 2022 | March 31, 2027 | JUN, HO-WOOK | reporter.nih.gov |
| Vascular macrophages and T cells in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,612,239 | March 18, 2019 | February 28, 2026 | LEY, KLAUS F. | reporter.nih.gov |
| The Role of Altered Luminal Dynamics in OSA-Induced Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,610,156 | July 10, 2019 | June 30, 2024 | ZARRINPAR, AMIR | reporter.nih.gov |
| CSDE1 as a Post Transcriptional Regulator of the LDLR | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,610,060 | July 15, 2021 | June 30, 2025 | CHORBA, JOHN S | reporter.nih.gov |
| Slowing Atherothrombosis Progression through Indoor Air Filtration: A Crossover Trial in Hispanic and non-Hispanic Adults with Ischemic Heart Disease History | NIH | National Institute of Environmental Health Sciences | 2022 to 2024 | $2,604,505 | September 1, 2022 | June 30, 2027 | CHEN, ZHANGHUA | reporter.nih.gov |
| Platelet Expression of FcgammaRIIa and Arterial Hemodynamics to Predict Recurrent Stroke in Intracranial Atherosclerosis | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,591,032 | April 1, 2022 | October 31, 2025 | LIEBESKIND, DAVID SIGMUND | reporter.nih.gov |
| Mechanisms and Modulation of Accelerated Atherosclerosis in Clonal Hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,584,743 | April 1, 2022 | August 31, 2026 | LIBBY, PETER | reporter.nih.gov |
| Using AI on Routine Clinical and Imaging Data from Acute Stroke Encounter to Predict Post-Stroke Vascular Contributions to Cognitive Impairment (AI - RESPECT) | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $2,575,013 | September 1, 2024 | July 31, 2027 | HU, XIAO | reporter.nih.gov |
| Cell-specific role and therapeutic potential of KCa3.1 in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,572,517 | April 1, 2022 | March 31, 2027 | BOWLES, DOUGLAS K | reporter.nih.gov |
| Clonal Hematopoiesis of Indeterminate Potential in Chronic Kidney Disease Patients | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $2,555,588 | July 2, 2022 | March 31, 2027 | KELLY, TANIKA NICOLE | reporter.nih.gov |
| Lipoprotein Metabolism and Excess Cardiometabolic Risk in South Asians | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,550,184 | September 15, 2022 | June 30, 2027 | ROHATGI, ANAND KUMAR | reporter.nih.gov |
| Novel insights into the molecular and cellular mechanism regulating lipid metabolism and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,550,177 | February 1, 2017 | January 31, 2024 | FERNANDEZ HERNANDO, CARLOS | reporter.nih.gov |
| Development of a multi-modal targeted nanotherapeutic to prevent restenosis in an atherosclerotic environment | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,544,484 | July 18, 2022 | June 30, 2027 | TSIHLIS, NICK DIMITRIOS | reporter.nih.gov |
| Role of PXR in EDC-induced cardiovascular disease | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $2,536,895 | June 5, 2023 | March 31, 2031 | ZHOU, CHANGCHENG | reporter.nih.gov |
| Dual Functionality of Ceramide in Human Microvascular Endothelial Function | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,525,399 | July 1, 2022 | June 30, 2027 | FREED, JULIE K | reporter.nih.gov |
| Integrating Coronary Atherosclerosis with Physiologic Features for Optimized Risk Stratification | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,517,408 | March 4, 2021 | February 28, 2026 | STONE, PETER HOWARD | reporter.nih.gov |
| IGF::OT::IGF ATHEROSCLEROSIS IN RISK COMMUNITIES - COORDINATING CENTER - CORE STUDY OPERATIONS | NIH | National Heart, Lung, and Blood Institute | 2021 | $2,517,180 | November 15, 2016 | November 14, 2021 | COUPER, DAVID | reporter.nih.gov |
| CD45-mediated endothelial-to-mesenchymal transition in cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,516,934 | January 15, 2020 | December 31, 2025 | CHEN, HONG | reporter.nih.gov |
| Intravascular microstructural, chemical and biomechanical characterization of coronary plaques | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,503,838 | August 1, 2022 | April 30, 2027 | URIBE-PATARROYO, NESTOR | reporter.nih.gov |
| A hypercholesterolemia-induced immunometabolite in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,499,404 | December 1, 2021 | November 30, 2025 | SHAH, PREDIMAN KRISHAN | reporter.nih.gov |
| Licensing LncRNAs in Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,495,305 | December 15, 2020 | November 30, 2025 | SALLAM, TAMER | reporter.nih.gov |
| Multiparametric PET/MRI Assessment of Mast Cell Stabilization Effects on Inflammaging and Glucose Utilization in Infarcted Myocardium | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,488,056 | April 1, 2023 | March 31, 2027 | COKIC, IVAN | reporter.nih.gov |
| 3D Multi-Functional Catheter-Based Imaging of Coronary Lesion Composition, Structure, and Hemodynamics in Intermediate Stenoses | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2024 | $2,487,260 | July 1, 2021 | March 31, 2026 | LINDSEY, BROOKS D | reporter.nih.gov |
| Coronary plaque changes with statin and colchicine among people with high polygenic risk- a mechanistic pilot study | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,484,226 | July 1, 2023 | June 30, 2028 | FAHED, AKL C | reporter.nih.gov |
| TABA for SAVE-FistulaS: A Pivotal Study of SelfWrap-Assisted ArterioVEnous FistulaS | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,474,784 | April 15, 2020 | April 30, 2027 | BOIRE, TIMOTHY CHARLES | reporter.nih.gov |
| Cell-Selective Therapies for Coronary Artery Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,469,740 | July 15, 2015 | December 31, 2026 | TOTARY-JAIN, HANA | reporter.nih.gov |
| PIK3C3, a master regulator for smooth muscle identity | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,467,369 | December 1, 2021 | November 30, 2026 | ZHOU, JILIANG | reporter.nih.gov |
| Chylomicrons and endothelial biology | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,467,094 | January 1, 2023 | December 31, 2026 | GOLDBERG, IRA J | reporter.nih.gov |
| Genetic modifiers of atherosclerosis and macrophage phenotypes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,457,383 | July 1, 2021 | June 30, 2026 | SMITH, JONATHAN D | reporter.nih.gov |
| Dissecting the Role of Arachidonic Acid Metabolic Pathways Involved in Resolution Versus Progression of PM-Induced Cardiometabolic Toxicity | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $2,445,294 | February 11, 2022 | November 30, 2026 | ARAUJO, JESUS ANTONIO | reporter.nih.gov |
| A novel psychological-behavioral intervention to promote physical activity after acute coronary syndrome | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,439,296 | June 1, 2022 | June 30, 2027 | HUFFMAN, JEFF C | reporter.nih.gov |
| Gut microbial metabolites and risk of coronary heart disease: a prospective, multiethnic, metabolomic study | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,429,547 | July 15, 2020 | June 30, 2025 | YU, DANXIA | reporter.nih.gov |
| Proteomics of Cardiovascular Risk: The Multiethnic Study of Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,419,606 | July 2, 2021 | April 30, 2026 | GANZ, PETER | reporter.nih.gov |
| Mapping MTP lipid transfer activities for better therapeutics | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,418,719 | April 1, 2021 | March 31, 2026 | HUSSAIN, M MAHMOOD | reporter.nih.gov |
| miR-181b, endothelial cells, and vascular inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,414,330 | August 1, 2012 | July 31, 2026 | FEINBERG, MARK W | reporter.nih.gov |
| Lp(a) and Oxidized Phospholipids - Impact of Diets | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,411,319 | December 15, 2021 | November 30, 2026 | BYAMBAA, ENKHMAA | reporter.nih.gov |
| Role of IL-6 trans signaling in atherosclerosis development and late-stage pathogenesis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,401,494 | April 15, 2023 | March 31, 2027 | OWENS, GARY K | reporter.nih.gov |
| Chronic Renal Insufficiency and Silent Progression of Aortic Stenosis (CRISP-AS) | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,398,742 | July 1, 2023 | June 30, 2028 | STROM, JORDAN BLAIR | reporter.nih.gov |
| Polymorphic ApoE at the crossroad of lipid metabolism and inflammation in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,398,270 | December 1, 2021 | November 30, 2026 | HUI, DAVID YIU-KWAN | reporter.nih.gov |
| TOPMed Omics of Cardiovascular Disease in Diabetes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,397,368 | July 1, 2020 | June 30, 2025 | MEIGS, JAMES B | reporter.nih.gov |
| SPHINGOLIPID BIOLOGY OF MACROPHAGE IN CORONARY ATHEROSCLEROSIS DEVELOPMENT AND PROGRESSION | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,395,181 | January 1, 2021 | December 31, 2025 | DI LORENZO, ANNARITA | reporter.nih.gov |
| Women's Ischemia Syndrome Evaluation (WISE) - Mechanisms of Coronary Microvascular Dysfunction Leading to Pre-Heart Failure with Preserved Ejection Fraction (HFpEF) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,389,719 | May 1, 2019 | February 28, 2026 | BAIREY MERZ, CATHLEEN NOEL | reporter.nih.gov |
| Role of Smooth Muscle Cell Insulin Resistance and Systemic Metabolic Dysfunction in Atherosclerosis Development and Late Stage Lesion Pathogenesis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,389,239 | July 15, 2023 | June 30, 2027 | OWENS, GARY K | reporter.nih.gov |
| Electrocardiographic Detection of Non-ST Elevation Myocardial Events for Accelerated Classification of Chest Pain Encounters (ECG-SMART 2) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,387,374 | April 15, 2018 | June 30, 2026 | AL-ZAITI, SALAH S | reporter.nih.gov |
| Investigating the role of CaV1.2 in aortic valve stenosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,384,826 | June 1, 2020 | May 31, 2025 | PITT, GEOFFREY S | reporter.nih.gov |
| Histone H3 O-GlcNAcylation in Endothelial Cells Promotes Diabetic Vascular Complications | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2025 | $2,381,683 | September 7, 2025 | August 31, 2029 | HE, MING | reporter.nih.gov |
| Nck adaptor proteins in atherogenic endothelial activation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,381,461 | June 1, 2016 | March 31, 2026 | ORR, ANTHONY WAYNE | reporter.nih.gov |
| Inflammation-resolution impairments in aging and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,376,589 | June 1, 2023 | May 31, 2027 | FREDMAN, GABRIELLE | reporter.nih.gov |
| Discovering Wdfy3 as a novel regulator of macrophage efferocytosis by genome-wide CRISPR screen | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,375,761 | May 1, 2020 | April 30, 2026 | ZHANG, HANRUI | reporter.nih.gov |
| Molecular mechanisms of vascular calcification and their connection to coronary disease risk | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,360,671 | August 1, 2022 | May 31, 2027 | QUERTERMOUS, THOMAS | reporter.nih.gov |
| Endothelial cell- specific Wnt suppression ameliorates vascular inflammation | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,355,120 | March 1, 2016 | December 31, 2025 | GOODWIN, JULIE | reporter.nih.gov |
| Methods for Enhancing Polygenic Risk Prediction Models for Complex Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,346,100 | July 1, 2023 | April 30, 2027 | KIM, DOKYOON | reporter.nih.gov |
| Mechanisms by which Small Nucleolar RNAs Exacerbate Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,336,220 | August 1, 2022 | June 30, 2026 | FREEDMAN, NEIL J. | reporter.nih.gov |
| Durable Schistosome induced metabolic alterations to the myeloid lineage | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,333,788 | March 5, 2021 | February 28, 2026 | FAIRFAX, KEKE CELESTE | reporter.nih.gov |
| Impact of Treating Asymptomatic CMV Replication on Cardiovascular Risk in Treated HIV Infection | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,331,970 | August 20, 2020 | July 31, 2025 | HUNT, PETER W | reporter.nih.gov |
| Integrative genomic and functional genomic studies to connect variant to function for CAD GWAS loci | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,327,515 | April 1, 2023 | March 31, 2027 | ZHANG, HANRUI | reporter.nih.gov |
| Pericoronary fat: MACE risk from non-contrast CT and the role of iodine perfusion in contrast CT | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,315,094 | February 15, 2023 | January 31, 2027 | WILSON, DAVID LYNN | reporter.nih.gov |
| MRI Detection of CarotId Plaques as a mecHanism for Embolic strokes of undeteRmined source (MRI DECIPHER) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,314,237 | August 15, 2019 | July 31, 2025 | KAMEL, HOOMAN | reporter.nih.gov |
| Investigating Cellular Immunometabolic Mechanisms Underlying HIV-Related Cardiovascular Disease Risk | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,303,944 | September 20, 2021 | August 31, 2025 | CORLEY, MICHAEL JAY | reporter.nih.gov |
| Glucose homeostasis and the risk of Alzheimer's disease and Alzheimer's disease related dementias in the Multi-Ethnic Study of Atherosclerosis | NIH | National Institute on Aging | 2021 | $2,295,981 | September 30, 2021 | August 31, 2024 | MONGRAW-CHAFFIN, MORGANA LEE | reporter.nih.gov |
| Mechanical characterization of carotid plaques for stroke risk assessment | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,295,392 | July 1, 2023 | April 30, 2028 | KONOFAGOU, ELISA E. | reporter.nih.gov |
| Fluid shear stress mechanotransduction at endothelial cell-cell junctions | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,292,108 | January 1, 2021 | December 31, 2024 | SCHWARTZ, MARTIN A | reporter.nih.gov |
| Structure-Function Analysis of Triglyceride Regulator ApoA-V Using Natural Variants | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,289,632 | July 1, 2016 | March 31, 2024 | RADER, DANIEL JAMES | reporter.nih.gov |
| Functional genomics investigation of pleiotropic vascular disease loci | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,287,605 | June 15, 2022 | May 31, 2027 | MILLER, CLINT L | reporter.nih.gov |
| Investigating the impact of a fatty acid-cRel inflammatory circuit in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,284,241 | April 1, 2021 | March 31, 2026 | BENSINGER, STEVEN J | reporter.nih.gov |
| PTEN promoter hypermethylation underlies vascular disease progression | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,283,283 | January 20, 2021 | December 31, 2025 | WEISER-EVANS, MARY CM | reporter.nih.gov |
| Preeclampsia to cardiovascular disease: Life course analysis of biomarkers and risk | NIH | National Heart, Lung, and Blood Institute | 2021 | $2,278,257 | September 1, 2018 | August 31, 2024 | HLATKY, MARK A. | reporter.nih.gov |
| Flow regulation of the Alk1/Eng pathway in vascular homeostasis and disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,277,780 | July 15, 2023 | May 31, 2027 | EICHMANN, ANNE CHRISTINE | reporter.nih.gov |
| Elucidation of P2X7 Receptor Signaling and Development of Novel Small Molecule and Aptamer Ligand Therapies | NIH | National Institute of General Medical Sciences | 2022 to 2025 | $2,276,100 | September 1, 2022 | August 31, 2027 | MANSOOR, STEVEN ELIAS | reporter.nih.gov |
| Integrated prediction of cardiovascular events by automated coronary plaque and pericoronary adipose tissue quantification from CT Angiography | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,275,582 | May 15, 2020 | March 31, 2025 | DEY, DAMINI | reporter.nih.gov |
| Artery biomechanics and vascular damage in sickle cell disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,274,529 | May 1, 2021 | April 30, 2026 | BOTCHWEY, EDWARD A. | reporter.nih.gov |
| Coronary Atherosclerosis and Immune Activation in HIV and Tuberculosis Infection | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,274,138 | August 2, 2022 | July 31, 2027 | HUAMAN JOO, MOISES ARTURO | reporter.nih.gov |
| Complement factor H modulates lipoprotein clearance in AMD | NIH | National Eye Institute | 2021 to 2024 | $2,266,452 | August 1, 2020 | July 31, 2025 | BOWES RICKMAN, CATHERINE | reporter.nih.gov |
| A dual-layer flat panel x-ray detector based on an engineered amorphous chalcogenide alloy for quantifying coronary artery calcium | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,262,800 | September 7, 2022 | May 31, 2027 | ABBASZADEH, SHIVA | reporter.nih.gov |
| Phosphatidylinositol Metabolism and Trafficking in Atherosclerosis and Inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,257,637 | April 1, 2020 | June 30, 2028 | GULSHAN, KAILASH | reporter.nih.gov |
| Elucidating the Biology of Cardiovascular Risk in Hemodialysis Patients Using Proteomics | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $2,255,523 | August 15, 2022 | April 30, 2026 | DUBIN, RUTH | reporter.nih.gov |
| Phase resolved ARF optical coherence elastography for intravascular imaging | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,255,269 | August 15, 2014 | June 30, 2026 | CHEN, ZHONGPING | reporter.nih.gov |
| Human Atherogenesis with Underlying Dysfunctional HDL-Free Cholesterol | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,250,059 | April 4, 2023 | February 28, 2027 | POWNALL, HENRY J. | reporter.nih.gov |
| Molecular predictors of cardiovascular events and resilience in chronic coronary artery disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,248,079 | August 15, 2023 | May 31, 2028 | NEWMAN, JONATHAN D | reporter.nih.gov |
| Role of CEBPb in flow-dependent endothelial dysfunction and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,242,336 | March 15, 2023 | February 28, 2027 | JO, HANJOONG | reporter.nih.gov |
| Development, Validation, and Harmonization of Methods for Collection and Measurement of NAD+ and Related Metabolites: Application to a Randomized Trial of Patients Undergoing Coronary Artery Bypass | NIH | National Institute on Aging | 2024 to 2025 | $2,233,900 | September 1, 2024 | August 31, 2029 | BHASIN, SHALENDER | reporter.nih.gov |
| Targeting Tfh Cell Metabolic Regulation in SLE and SLE-Associated Atherosclerosis | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $2,227,644 | May 20, 2020 | April 30, 2026 | RATHMELL, JEFFREY C. | reporter.nih.gov |
| Automated Intracranial Vessel Wall Analysis Pipeline for Multi-contrast Multi-platform Applications | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,221,498 | September 1, 2022 | August 31, 2027 | YUAN, CHUN | reporter.nih.gov |
| Coronary Artery Calcium, Aortic Calcification and Density in MESA | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,221,188 | April 1, 2020 | March 31, 2025 | BUDOFF, MATTHEW J | reporter.nih.gov |
| Targeting the gut-liver axis in cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,220,868 | December 15, 2022 | November 30, 2026 | VALLIM, THOMAS A | reporter.nih.gov |
| Toward Personalized Therapeutics: Directed Remodeling of the Gut Microbiome to Treat Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,216,742 | April 22, 2020 | September 30, 2024 | GHADIRI, M. REZA | reporter.nih.gov |
| The role of hepatocyte tPA in hepatic VLDL production. | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,208,015 | April 5, 2022 | March 31, 2027 | ZHENG, ZE | reporter.nih.gov |
| Quantitative coronary flow capacity with low-dose CT for ischemia but no obstructive coronary artery disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,195,209 | July 1, 2023 | April 30, 2028 | MOLLOI, SABEE | reporter.nih.gov |
| Molecular Determinants of Atherosclerotic Cardiovascular Disease in Multi-ethnic Populations | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,191,699 | April 1, 2023 | March 31, 2027 | YU, BING | reporter.nih.gov |
| Improving Lipid Management Strategies in Young Adults | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,182,889 | April 5, 2023 | January 31, 2027 | ZHANG, YIYI | reporter.nih.gov |
| MULTI-ETHNIC STUDY OF ATHEROSCLEROSIS (MESA) - TASK AREA A | NIH | National Heart, Lung, and Blood Institute | 2025 | $2,180,149 | April 12, 2025 | December 18, 2025 | MCCLELLAND, ROBYN LEAGH | reporter.nih.gov |
| Coronary Atherosclerotic Burden in AsA-NHPI: the Role of the Gut Microbiome | NIH | National Heart, Lung, and Blood Institute | 2025 | $2,177,784 | September 12, 2025 | June 30, 2029 | AHN, JIYOUNG | reporter.nih.gov |
| Premature aging disorders, metabolites, and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,173,716 | December 15, 2022 | November 30, 2026 | ABE, JUN-ICHI | reporter.nih.gov |
| Mechanistic Studies of the Novel Human Coronary Artery Disease Gene SVEP1 | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,173,015 | April 1, 2022 | February 28, 2027 | STITZIEL, NATHAN OLIVER | reporter.nih.gov |
| Lipoprotein Interactions in the Vessel Wall | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,172,541 | April 1, 2021 | March 31, 2026 | SHAH, AMY SANGHAVI | reporter.nih.gov |
| Early Detection of Vascular Dysfunction Using Biomarkers from Lagrangian Carotid Strain Imaging | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,172,540 | July 15, 2020 | June 30, 2025 | VARGHESE, TOMY | reporter.nih.gov |
| Subendothelial Exosomes in Coronary Microvascular Dysfunction | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,167,298 | March 15, 2004 | March 31, 2026 | LI, PINLAN | reporter.nih.gov |
| Multi-omic signatures of gut dysbiosis and cardiovascular comorbidities associated with HIV infection | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,163,847 | September 1, 2023 | May 31, 2027 | QI, QIBIN | reporter.nih.gov |
| Influence of T cell genotype/phenotype in atherosclerotic cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,163,599 | June 1, 2023 | May 31, 2027 | GUMINA, RICHARD J | reporter.nih.gov |
| Fibroblast growth factor 1 prevents hyperlipidemia and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,163,369 | December 1, 2021 | November 30, 2026 | TAN, YI | reporter.nih.gov |
| Novel Function of Native Low-Density Lipoprotein in Inflammation | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $2,161,732 | September 21, 2021 | July 31, 2025 | ZAKI, HASAN | reporter.nih.gov |
| Mechanisms Regulating Vascular Homeostasis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,160,566 | September 1, 2021 | July 31, 2025 | KONTOS, CHRISTOPHER D | reporter.nih.gov |
| Atherogenic Mechanisms of Electronic Nicotine Delivery Systems | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,160,337 | January 1, 2020 | December 31, 2024 | SRIVASTAVA, SANJAY | reporter.nih.gov |
| Atherothrombosis in JAK2V617F clonal hematopoiesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,159,282 | June 1, 2019 | May 31, 2028 | WANG, NAN | reporter.nih.gov |
| Macrophages in homeostasis and cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,158,562 | June 25, 2021 | February 28, 2024 | SWIRSKI, FILIP K | reporter.nih.gov |
| Informing best practices for evaluation and treatment of myocardial injury during sepsis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,156,394 | September 1, 2023 | June 30, 2027 | WALKEY, ALLAN J. | reporter.nih.gov |
| Acetate and Endothelial Pathobiology | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,156,080 | May 15, 2023 | April 30, 2027 | ARANY, ZOLTAN P | reporter.nih.gov |
| Role of PXR in drug-elicited cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,135,638 | December 15, 2022 | November 30, 2026 | ZHOU, CHANGCHENG | reporter.nih.gov |
| Role of IL-32 as a predictor and mediator of Premature Aging Phenotypes(PAP) in HIV infection. | NIH | National Institute on Aging | 2022 to 2025 | $2,130,370 | September 30, 2016 | April 30, 2027 | TREMBLAY, CECILE | reporter.nih.gov |
| Critical role of Mitochondrial Fission/Fusion in Regulation of Microvascular Endothelial Function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,127,892 | August 1, 2021 | July 31, 2025 | BEYER, ANDREAS M | reporter.nih.gov |
| TRP channels in the regulation of vascular tone | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,126,388 | February 4, 2011 | June 30, 2026 | ZHANG, DAVID X. | reporter.nih.gov |
| Immunometabolism and the Cardio-Renal Axis in T1D-associated Atherosclerosis: Insights from the CaRe T1D Biobank | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,123,110 | September 18, 2024 | June 30, 2027 | BORNFELDT, KARIN E | reporter.nih.gov |
| Development of multifunctional drug and immune modulator delivery nanoparticles for the treatment of cancer patients with comorbid atherosclerosis | NIH | National Cancer Institute | 2021 to 2025 | $2,122,501 | February 1, 2021 | January 31, 2026 | YANG, LILY | reporter.nih.gov |
| Regulation of Endothelial Lipid Metabolism in the Setting of Diabetes and Critical Limb Ischemia to Prevent Surgical Complications | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,122,345 | April 1, 2021 | March 31, 2026 | ZAYED, MOHAMED A. | reporter.nih.gov |
| Role of platelet- monocyte interaction in promoting pro-atherogenic state in HIV-infected individuals | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,116,129 | August 1, 2022 | July 31, 2027 | THAKAR, JUILEE | reporter.nih.gov |
| Molecular and Cellular Regulation of Vascular Calcification | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $2,114,102 | January 4, 2024 | December 31, 2030 | GIACHELLI, CECILIA M | reporter.nih.gov |
| EHD1-mediated Inflammation and Resolution in Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,113,751 | May 1, 2023 | August 10, 2025 | CAI, BISHUANG | reporter.nih.gov |
| Genomic and Proteomic Architecture of Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 | $2,113,515 | July 18, 2012 | January 31, 2024 | HERRINGTON, DAVID MCLEOD | reporter.nih.gov |
| Influence of sleep on the hematopoietic niche and atherosclerosis during aging | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $2,113,125 | July 1, 2021 | May 31, 2026 | MCALPINE, CAMERON STUART | reporter.nih.gov |
| Smooth muscle cell-derived cell fates and cellular interactions in atherosclerotic plaque stability in disease progression and regression. | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,105,241 | January 1, 2023 | December 31, 2026 | REILLY, MUREDACH P | reporter.nih.gov |
| Monocyte chemoattractant Proteins and Vascular Injury | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $2,102,067 | July 1, 2023 | April 30, 2027 | MISRA, SANJAY | reporter.nih.gov |
| Uncertainty aware virtual treatment planning for peripheral pulmonary artery stenosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,093,561 | July 1, 2023 | June 30, 2028 | MARSDEN, ALISON L | reporter.nih.gov |
| Mechanisms of drug-coated balloon therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,085,520 | September 1, 2021 | August 31, 2025 | KOLACHALAMA, VIJAYA B. | reporter.nih.gov |
| Dimensions of Kidney Tubule Health and Atherosclerotic Cardiovascular Disease and Heart Failure in Middle-Aged and Older Adults | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,079,493 | December 25, 2022 | November 30, 2026 | SARNAK, MARK J | reporter.nih.gov |
| Structural basis for cardioprotective HDL | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,073,696 | December 15, 2019 | November 30, 2024 | HEINECKE, JAY W | reporter.nih.gov |
| Psycho-neuro-immune Mechanisms Linking Stigma and Discrimination to Carotid Plaque Formation in Persons living with HIV | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,070,058 | August 15, 2023 | July 31, 2027 | MCINTOSH, ROGER CHRISTOPHER | reporter.nih.gov |
| Trial to Assess Chelation Therapy 2- TACT2 CCC | NIH | National Center for Complementary & Integrative Health | 2021 | $2,069,251 | September 30, 2015 | April 30, 2022 | LAMAS, GERVASIO A | reporter.nih.gov |
| Plasma Sphingolipids and Subclinical and Clinical Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,065,256 | June 24, 2020 | May 31, 2026 | LEMAITRE, ROZENN | reporter.nih.gov |
| A Study Evaluating the Safety and Efficacy of Second-Generation Tissue Engineered Vascular Grafts (TEVG2) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,061,658 | September 11, 2019 | February 28, 2026 | BREUER, CHRISTOPHER KANE | reporter.nih.gov |
| Unraveling ApoE4 Promotion of Cardiometabolic Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,058,431 | July 1, 2020 | April 30, 2025 | SHAUL, PHILIP W | reporter.nih.gov |
| Molecular Basis of Exercise-induced Changes in HDL Function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,055,851 | April 1, 2019 | March 31, 2025 | SARZYNSKI, MARK ANDREW | reporter.nih.gov |
| Epigenetic mechanisms linking psychosocial stress with coronary heart disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $2,054,791 | April 1, 2022 | March 31, 2027 | ZANNAS, ANTHONY S. | reporter.nih.gov |
| Stroke Minimization through Additive Anti-atherosclerotic Agents in Routine Treatment II Study | NIH | National Institute of Neurological Disorders and Stroke | 2022 to 2025 | $2,050,132 | September 1, 2022 | August 31, 2027 | OVBIAGELE, BRUCE | reporter.nih.gov |
| Cellular and Circulating Fortilin in Vascular Diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,049,720 | January 15, 2013 | July 31, 2025 | FUJISE, KEN | reporter.nih.gov |
| Discovery and therapeutic targeting non-coding RNAs in T1D- or T2D-associated atherosclerosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,045,222 | September 18, 2024 | June 30, 2027 | FEINBERG, MARK W | reporter.nih.gov |
| Insulin-Like Growth Factor-1 and Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,035,860 | December 5, 2002 | June 30, 2027 | DELAFONTAINE, PATRICE | reporter.nih.gov |
| Characterization of risk factors for excessive cardiovascular diseases (CVD) from circulating and cardiovascular tissues of people with well-controlled chronic type 1 diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $2,029,432 | September 18, 2024 | June 30, 2027 | KING, GEORGE L | reporter.nih.gov |
| Clinical and economic value of novel diabetes medications for prevention of cardiovascular disease in type 2 diabetes | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,024,083 | May 1, 2021 | April 30, 2025 | FERKET, BART | reporter.nih.gov |
| Universal optical coherence polarimetry | NIH | National Institute of Biomedical Imaging and Bioengineering | 2022 to 2025 | $2,020,013 | July 15, 2022 | April 30, 2026 | VILLIGER, MARTIN | reporter.nih.gov |
| Inflammation and delayed cognitive dysfunction after stroke | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $2,016,915 | March 15, 2023 | February 28, 2026 | DOYLE, KRISTIAN PAUL | reporter.nih.gov |
| Clinical benefits and mechanism of action of angiotensin-II receptor blocker on Cardiovascular remodeling in patients with repaired coarctation of aorta | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,012,689 | August 25, 2023 | July 31, 2028 | EGBE, ALEXANDER | reporter.nih.gov |
| Comprehensive CT Guided Coronary Artery Bypass Graft Surgery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,010,927 | February 15, 2019 | January 31, 2026 | NIEMAN, KOEN | reporter.nih.gov |
| High-throughput cellular genetics to connect noncoding variants to coronary artery disease genes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $2,007,839 | April 1, 2023 | March 31, 2027 | GUPTA, RAJAT M | reporter.nih.gov |
| Senescence dysregulates of inflammation-resolution programs in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $2,006,128 | July 15, 2020 | June 30, 2024 | FREDMAN, GABRIELLE | reporter.nih.gov |
| The Role of Arylsulfatase in Vascular Calcification | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,995,798 | April 1, 2023 | March 31, 2027 | MALHOTRA, RAJEEV | reporter.nih.gov |
| Examining Susceptibility and Resistance Phenotypes to Enhance Understanding of the Genetic Basis of Major Coronary Artery Disease in Type 1 Diabetes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,995,149 | July 27, 2022 | June 30, 2027 | MILLER, RACHEL GRACE | reporter.nih.gov |
| Cardiac CT Deblooming | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,994,352 | September 1, 2020 | March 15, 2024 | DE MAN, BRUNO | reporter.nih.gov |
| Comprehensive characterization of coronary atherosclerotic disease using photon-counting-detector dual-source CT and its impact on patient management | NIH | National Institute of Biomedical Imaging and Bioengineering | 2021 to 2023 | $1,988,559 | May 1, 2020 | July 31, 2025 | MCCOLLOUGH, CYNTHIA H | reporter.nih.gov |
| Apolipoprotein conformation in amyloid and cardiovascular diseases | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,987,207 | December 15, 1998 | August 31, 2025 | GURSKY, OLGA | reporter.nih.gov |
| Establishing mechanistic links between the gut microbiome and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,985,767 | April 1, 2020 | March 31, 2025 | REY, FEDERICO E | reporter.nih.gov |
| Identification of smooth muscle cell genes causal in atherosclerotic plaque stability and cardiovascular disease risk | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,981,673 | August 10, 2023 | June 30, 2027 | REILLY, MUREDACH P | reporter.nih.gov |
| Role of apoE in HDL-mediated enhanced survival of human regulatory T-cells | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,980,380 | January 1, 2023 | December 31, 2026 | CHOUGNET, CLAIRE A. | reporter.nih.gov |
| The characterization of Cela2a, a novel disease gene for metabolic syndrome in health and diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,979,595 | April 1, 2023 | March 31, 2028 | MANI, ARYA | reporter.nih.gov |
| Interplay Between Macrophages, Lipid Oxidation and the Nrf2/HO-1 Axis in the Cardiometabolic Toxicity Induced by Ultrafine Particles | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $1,975,843 | May 8, 2021 | February 28, 2027 | ARAUJO, JESUS ANTONIO | reporter.nih.gov |
| Computational and functional strategies to decipher lncRNAs in human atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,972,315 | February 1, 2020 | January 31, 2025 | REILLY, MUREDACH P | reporter.nih.gov |
| Lifespan and Cardiovascular Health Effects on The Brain in Humans and Great Ape | NIH | National Institute on Aging | 2024 to 2025 | $1,966,730 | September 17, 2024 | May 31, 2029 | HOF, PATRICK R | reporter.nih.gov |
| Rapid Comprehensive Cardiac MRI Exam for Diagnosis of Coronary Artery Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,965,752 | May 26, 2020 | April 30, 2026 | AKCAKAYA, MEHMET | reporter.nih.gov |
| Stress, inflammation and coronary endothelial injury in preeclampsia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,961,087 | September 2, 2022 | June 30, 2027 | HAYS, ALLISON G | reporter.nih.gov |
| The Role and Mechanisms of Lipid and Lipoprotein Dysregulation in Sepsis | NIH | National Institute of General Medical Sciences | 2021 to 2024 | $1,960,279 | April 1, 2020 | March 31, 2026 | GUIRGIS, FAHEEM W | reporter.nih.gov |
| Sensing and Clearance of Damaged Lysosomes in Macrophages and Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,949,485 | November 4, 2014 | June 30, 2026 | RAZANI, BABAK | reporter.nih.gov |
| Bayesian machine learning for causal inference with incomplete longitudinal covariates and censored survival outcomes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,940,844 | May 15, 2022 | April 30, 2027 | HU, LIANGYUAN | reporter.nih.gov |
| LysoPI/GPR55 pathway promotes endothelial activation, vascular inflammation and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,940,100 | January 1, 2023 | December 31, 2026 | YANG, XIAOFENG | reporter.nih.gov |
| Transvenous Optoacoustic-Ultrasound Guided Cold Laser Wire for Crossing Coronary Chronic Total Occlusion | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,934,572 | May 1, 2022 | April 30, 2026 | MILNER, THOMAS E | reporter.nih.gov |
| Integrated omics analysis of clonal hematopoiesis and cardiovascular disease risk in TOPMed | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,932,014 | July 19, 2023 | June 30, 2027 | CONNEELY, KAREN | reporter.nih.gov |
| Leveraging the mitochondrial regulator MIRO1 to prevent neointimal hyperplasia | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,926,265 | December 1, 2021 | May 31, 2025 | GRUMBACH, ISABELLA MARIA | reporter.nih.gov |
| Hepatic Rap1a in cholesterol homeostasis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,924,525 | August 1, 2023 | June 30, 2027 | OZCAN, LALE | reporter.nih.gov |
| Obesogenic diet-induced intestinal epithelium repair responses link dysbiosis and cardiovascular disease | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,922,837 | January 12, 2022 | December 31, 2026 | BYNDLOSS, MARIANA XAVIER | reporter.nih.gov |
| Molecular Drivers of Atherosclerosis in Diabetes | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2024 to 2025 | $1,910,575 | September 18, 2024 | June 30, 2027 | ONENGUT, SUNA | reporter.nih.gov |
| Molecular Mechanisms of TRIB1 Regulation of Hepatic Metabolism | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,907,161 | May 1, 2023 | April 30, 2027 | BAUER, ROBERT CLAYTON | reporter.nih.gov |
| CAPTIVA-MRI | NIH | National Institute of Neurological Disorders and Stroke | 2023 | $1,906,569 | April 15, 2023 | March 31, 2025 | DE HAVENON, ADAM H. | reporter.nih.gov |
| Preclinical imaging of immune responses to chronic stress | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,905,800 | July 1, 2023 | June 30, 2028 | VAN LEENT, MANDY MARIA THERESIA | reporter.nih.gov |
| Contributions of Hepatic and Intestinal Pathways to Cholesterol Excretion | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2025 | $1,904,680 | September 13, 2017 | March 31, 2027 | GRAF, GREGORY A | reporter.nih.gov |
| KLF control of aging and age-associated cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,902,000 | February 1, 2017 | February 28, 2022 | JAIN, MUKESH KUMAR | reporter.nih.gov |
| Nuclear FAK-mediated VSMC differentiation via epigenetic reprograming invascular diseases | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,892,164 | May 16, 2022 | March 31, 2027 | LIM, STEVE | reporter.nih.gov |
| SPECT Imaging of Peripheral Vascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,892,118 | September 1, 2019 | August 31, 2025 | MENG, LING-JIAN | reporter.nih.gov |
| Angiogenic Bioengineered Systems to Optimize Post-Infarction Myocardial Recovery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,891,065 | March 15, 2008 | February 28, 2026 | WOO, Y JOSEPH | reporter.nih.gov |
| Clinical and Molecular Epidemiology of High Risk Coronary Plaque | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,889,754 | August 1, 2019 | July 31, 2024 | SHAH, SVATI H. | reporter.nih.gov |
| Health Outcomes of Discontinuing Aspirin in Older Adults with Alzheimer's Disease and Related Dementias | NIH | National Institute on Aging | 2023 to 2025 | $1,883,720 | April 15, 2023 | January 31, 2027 | THORPE, CAROLYN TIMBERLAKE | reporter.nih.gov |
| Regulation of plasma LDL and HDL by microRNA-541-3p | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,882,991 | June 1, 2023 | May 31, 2027 | HUSSAIN, M MAHMOOD | reporter.nih.gov |
| Genetics of Cardiovascular Disease in Chronic Kidney Disease | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,872,629 | May 1, 2022 | April 30, 2026 | FRANCESCHINI, NORA | reporter.nih.gov |
| Contribution of nonrenal calcitriol production in chronic inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,871,655 | July 1, 2021 | June 30, 2025 | MEYER, MARK B | reporter.nih.gov |
| Social determinants of fatty liver disease and its racial/ethnic disparities: The Multi-Ethnic Study of Atherosclerosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,869,561 | July 15, 2023 | May 31, 2027 | LAZO ELIZONDO, MARIANA | reporter.nih.gov |
| Cell-free vascular grafts: immunological response and vascular regeneration | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,868,150 | April 10, 2020 | March 31, 2026 | ANDREADIS, STELIOS THEOHARIS | reporter.nih.gov |
| Dissecting the Impact of Dietary Protein on Macrophage mTOR Signaling and Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,860,977 | April 1, 2022 | April 30, 2027 | RAZANI, BABAK | reporter.nih.gov |
| Vascular calcification and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,860,950 | January 1, 2021 | December 31, 2026 | SAVINOVA, OLGA V. | reporter.nih.gov |
| 1/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD) | NIH | National Heart, Lung, and Blood Institute | 2024 | $1,858,859 | September 25, 2024 | August 31, 2025 | PATEL, MANESH R | reporter.nih.gov |
| Prevent Unnecessary Carotid Intervention and Stroke using Noninvasive Transcutaneous Ultrasound Thermal Strain Imaging (US-TSI) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,858,255 | June 15, 2020 | May 31, 2025 | KIM, KANG | reporter.nih.gov |
| 1/2 Low dose colchicine in pAtients with peripheral artery DiseasE to assess residual vascular risk (LEADER-PAD) | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,841,946 | September 25, 2024 | August 31, 2029 | PATEL, MANESH R | reporter.nih.gov |
| Biological Mechanisms through which TMAO Promotes Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,840,349 | April 20, 2020 | February 28, 2025 | ALLAYEE, HOOMAN | reporter.nih.gov |
| Therapeutic Potential of Estrogen-Regulated Metabolism and Cardiovascular Risk | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,835,045 | March 1, 2016 | April 30, 2025 | STAFFORD, JOHN MICHAEL | reporter.nih.gov |
| Systems Genetics of Vascular Smooth Muscle Phenotypes | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,820,349 | December 15, 2022 | June 30, 2025 | CIVELEK, METE | reporter.nih.gov |
| LncRNA SNHG12, vascular senescence, and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,815,925 | May 15, 2020 | April 30, 2024 | FEINBERG, MARK W | reporter.nih.gov |
| Using Genetics to Inform Mechanism of Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,814,970 | February 1, 2017 | June 30, 2022 | WILLER, CRISTEN J | reporter.nih.gov |
| Sensing Vulnerable Plaque in vivo by an All-optical Intravascular Ultrasound and Photoacoustic Catheter | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,804,444 | August 1, 2015 | August 31, 2025 | CHENG, JI-XIN | reporter.nih.gov |
| Opportunistic Atherosclerotic Cardiovascular Disease Risk Estimation at Abdominal CTs with Robust and Unbiased Deep Learning | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,796,488 | September 1, 2023 | May 31, 2028 | CHAUDHARI, AKSHAY | reporter.nih.gov |
| Integration of single-cell imaging and multi-omics sequencing to study EC mechano-pathophysiology | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,791,681 | December 20, 2013 | June 30, 2027 | WANG, YINGXIAO | reporter.nih.gov |
| Role of Retinoid X Receptor Alpha in regulating PCSK9 transcription in the liver | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,789,027 | April 1, 2023 | January 31, 2027 | MIAO, QING | reporter.nih.gov |
| Telomerase Reverse Transcriptase in Vascular Homeostasis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,784,019 | May 6, 2020 | April 30, 2025 | KEANEY, JOHN FRANCIS | reporter.nih.gov |
| FAT cadherins and vascular remodeling | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,780,272 | December 15, 2022 | November 30, 2026 | SIBINGA, NICHOLAS E | reporter.nih.gov |
| Effect of cell-based therapies on functional, hemodynamic, and histologic outcomes in a porcine model of peripheral arterial disease | NIH | National Institute on Aging | 2021 to 2023 | $1,779,273 | August 15, 2019 | March 31, 2025 | PIPINOS, IRAKLIS ILIAS | reporter.nih.gov |
| CD37 as a Regulator of Platelet Patho(Physiological) Responses | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,763,213 | July 15, 2023 | June 30, 2028 | BARRETT, TESSA | reporter.nih.gov |
| A culturally-tailored dietary trial for cardiometabolic health in Puerto Rico | NIH | National Institute on Minority Health and Health Disparities | 2023 to 2025 | $1,762,186 | July 19, 2023 | January 31, 2028 | MATTEI, JOSIEMER | reporter.nih.gov |
| IND-enabling Epicardial Biopharmaceutical in the Diabetic Heart | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,760,696 | August 15, 2018 | January 31, 2023 | RUIZ-LOZANO, PILAR | reporter.nih.gov |
| Elucidating the chromatin-dependent mechanisms governing chronic inflammatory activation of endothelial cells in atherosclerosis. | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,759,134 | April 1, 2020 | March 31, 2024 | BROWN, JONATHAN DAVID | reporter.nih.gov |
| Role of mitophagy in age-related respiratory and vascular diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,755,000 | January 1, 2021 | October 31, 2023 | GOLDSTEIN, DANIEL ROBERT | reporter.nih.gov |
| Integrating Risk Trajectories and Social Determinants to Enhance Cardiovascular Risk Assessment in Older Adults | NIH | National Institute on Aging | 2021 to 2025 | $1,751,963 | August 15, 2021 | April 30, 2027 | DUPRE, MATTHEW E. | reporter.nih.gov |
| Targeting Residual ASCVD Risk by Integrating Genetics and Clinical Data | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,736,459 | July 15, 2024 | June 30, 2028 | WEI, WEI-QI | reporter.nih.gov |
| Unraveling the Complexities of Lp(a): From Genes to Function | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,719,953 | August 1, 2018 | July 31, 2029 | REYES-SOFFER, GISSETTE | reporter.nih.gov |
| Post-transcriptional regulation of LDLR | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,715,540 | April 1, 2024 | March 31, 2028 | TARLING, ELIZABETH JOANNA | reporter.nih.gov |
| The Effects of Bundled Payment on Acute Cardiovascular Outcomes Among Older Adults | NIH | National Institute on Aging | 2023 to 2025 | $1,707,931 | September 1, 2015 | March 31, 2027 | RYAN, ANDREW M | reporter.nih.gov |
| Predicting Stroke Risk in Intracranial Atherosclerotic Disease with Novel High Resolution,Functional and Molecular MRI Techniques - Resubmission - 1 | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2024 | $1,705,735 | September 1, 2020 | June 30, 2025 | CARROLL, TIMOTHY J | reporter.nih.gov |
| Targets and targeting of immunometabolism in chronic PM2.5 exposure | NIH | National Institute of Environmental Health Sciences | 2022 to 2025 | $1,704,385 | February 7, 2022 | November 30, 2026 | MAISEYEU, ANDREI | reporter.nih.gov |
| Role of Splenic Pro-Resolving Mediators During Exposure to Particulate Air Pollution | NIH | National Institute of Environmental Health Sciences | 2023 to 2025 | $1,704,295 | May 1, 2023 | February 29, 2028 | SANSBURY, BRIAN EDWARD | reporter.nih.gov |
| APOC3 mediated dyslipidemia in diabetic kidney disease and atherosclerosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,701,057 | February 17, 2020 | January 31, 2026 | KANTER, JENNY E. | reporter.nih.gov |
| Biomimetic Vascular Matrix for Vascular Smooth Muscle Cell Mechanobiology and Pathology | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,696,127 | September 1, 2023 | June 30, 2027 | BAE, YONGHO | reporter.nih.gov |
| Macrophage-Lipoprotein Interactions | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,695,000 | July 1, 2009 | September 30, 2026 | MAXFIELD, FREDERICK R. | reporter.nih.gov |
| Hepatic mTORC1 Signaling and the Regulation of Lipid Homeostasis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2024 | $1,694,012 | March 1, 2021 | January 31, 2025 | TITCHENELL, PAUL MICHAEL | reporter.nih.gov |
| Imaging the Atherosclerosis Cascade in Sleep Apnea | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,691,501 | July 15, 2018 | May 31, 2025 | SHAH, NEOMI A | reporter.nih.gov |
| Dysregulations in Polyamine Metabolism During Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,688,538 | April 1, 2023 | March 31, 2028 | YURDAGUL, ARIF | reporter.nih.gov |
| Studying Atherosclerosis Macrophage Dynamics by Combined PET and Fluorine-MRI | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,682,636 | January 15, 2019 | December 31, 2023 | FAYAD, ZAHI A. | reporter.nih.gov |
| Platelet Activity and Vascular Health in Systemic Lupus Erythematosus | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,681,304 | January 1, 2018 | November 30, 2023 | BERGER, JEFFREY S | reporter.nih.gov |
| SMC macropinocytosis: a novel target in atherosclerotic vascular disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,679,752 | May 15, 2023 | April 30, 2028 | CSANYI, GABOR | reporter.nih.gov |
| Development of HLA engineered universal vascular grafts from human iPSCs | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,675,000 | August 1, 2021 | July 31, 2025 | QYANG, YIBING | reporter.nih.gov |
| Lipin-1 transcriptional coregulatory activity promotes macrophage pro-resolving response | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,674,762 | September 1, 2023 | July 31, 2027 | WOOLARD, MATTHEW DALE | reporter.nih.gov |
| The role of GATA3-positive macrophages in cardiovascular pathologies | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,670,000 | July 1, 2022 | June 30, 2026 | SHAH, PREDIMAN KRISHAN | reporter.nih.gov |
| The transcriptional regulation of smooth muscle genes by PRDM6 in vascular health and diseases | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,669,985 | December 11, 2023 | November 30, 2027 | MANI, ARYA | reporter.nih.gov |
| Shear stress Regulation of Endothelial Glycolysis via METTL3-mediated RNA m6A Modification | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,667,246 | July 1, 2024 | June 30, 2028 | SHYY, JOHN YJ | reporter.nih.gov |
| Pim1 kinase coordinates PPAR gamma pathway and mitochondrial function to mediate pro-atherogenic responses in macrophages | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,665,891 | April 1, 2021 | March 31, 2025 | SILVERSTEIN, ROY L | reporter.nih.gov |
| Mechanisms of cognitive impairment caused by atherosclerosis and red blood cell released ATP | NIH | National Institute of Neurological Disorders and Stroke | 2024 to 2025 | $1,653,797 | August 1, 2024 | July 31, 2029 | HE, PINGNIAN | reporter.nih.gov |
| SUMO2-p66shc axis in vascular endothelial dysfunction and atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,651,874 | April 1, 2020 | March 31, 2026 | KUMAR, SANTOSH | reporter.nih.gov |
| Molecular Regulation of Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,645,376 | February 1, 2019 | January 31, 2025 | CHEN, HONG | reporter.nih.gov |
| PFAS accelerate atherosclerosis through modulation of bile acid metabolism | NIH | National Institute of Environmental Health Sciences | 2023 | $1,644,161 | September 19, 2023 | August 31, 2026 | PETRIELLO, MICHAEL CURTIS | reporter.nih.gov |
| Chemical Biology to Modulate PCSK9 and Treat Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,640,324 | July 1, 2021 | March 31, 2025 | CHORBA, JOHN S | reporter.nih.gov |
| Role of LMO7 in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,637,057 | August 1, 2020 | July 31, 2025 | MARTIN, KATHLEEN ANN | reporter.nih.gov |
| Quantitative magnetization transfer MRI for evaluation of renal fibrosis | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2021 to 2023 | $1,634,690 | March 15, 2020 | January 31, 2025 | LERMAN, LILACH O | reporter.nih.gov |
| Immunophenotyping for precision medicine for cardiovascular disease in people living with HIV | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,634,008 | August 1, 2019 | July 31, 2025 | KAPLAN, ROBERT C | reporter.nih.gov |
| Virtual metabolomics as a discovery tool for novel cardiometabolic disease biology | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,628,814 | April 1, 2019 | March 31, 2025 | FERGUSON, JANE F | reporter.nih.gov |
| Circadian regulation of vascular aging | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,628,142 | January 18, 2019 | December 31, 2024 | CHEN, YABING | reporter.nih.gov |
| Comparing a Novel Telehealth-enabled Hybrid Cardiac Rehabilitation Program to Clinic-based Cardiac Rehabilitation for Improving Patient Engagement and Functional Outcomes after ACS | NIH | National Institute on Minority Health and Health Disparities | 2024 to 2025 | $1,628,101 | September 20, 2024 | May 31, 2029 | DURAN, ANDREA T | reporter.nih.gov |
| The Role of Food Sensitization in Cardiovascular Disease | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,626,865 | August 13, 2024 | July 31, 2029 | KEET, CORINNE | reporter.nih.gov |
| Lipidated Amino Acids in Cardiometabolic Diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2022 to 2025 | $1,621,509 | June 2, 2022 | March 31, 2027 | ROM, OREN | reporter.nih.gov |
| Mechanistic registry to study whether infection with Corona Virus Disease 2019 (COVID-19) alters atherosclerotic plaque progression | NIH | National Heart, Lung, and Blood Institute | 2021 | $1,620,596 | September 6, 2021 | September 7, 2021 | SHAW, LESLEE J | reporter.nih.gov |
| Epigenetic Determinants of Lipoproteins Across the Early Adult Life Course | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,618,997 | March 1, 2020 | February 28, 2025 | WILKINS, JOHN THOMAS | reporter.nih.gov |
| Mechanisms linking insulin action with lipoprotein metabolism | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,617,709 | November 21, 2014 | June 30, 2025 | HAEUSLER, REBECCA ANNE | reporter.nih.gov |
| Role of the TLR4 signaling in smooth muscle cell phenotypic transition | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,610,000 | August 1, 2021 | July 31, 2026 | CHEREPANOVA, OLGA | reporter.nih.gov |
| Targeting Endothelial Epsins to Ameliorate Myocardial Ischemia | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,609,612 | July 8, 2024 | June 30, 2028 | CHEN, HONG | reporter.nih.gov |
| Clonal Hematopoiesis in Healthy Individuals from Families with Early OnsetCoronary Artery Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,606,957 | May 1, 2019 | April 30, 2025 | BECKER, LEWIS C | reporter.nih.gov |
| NKA/CD36 signaling in adipocytes promotes oxidative stress and drives chronic inflammation in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,604,907 | April 1, 2023 | March 31, 2027 | SILVERSTEIN, ROY L | reporter.nih.gov |
| Unique value of real-time shear stress to enhance coronary disease management | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,603,334 | January 1, 2018 | December 31, 2024 | TEARNEY, GUILLERMO J | reporter.nih.gov |
| Metabolism and cell cycle as mediators of fluid shear stress effects on vascular endothelium in health and disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,596,686 | August 13, 2024 | May 31, 2028 | SCHWARTZ, MARTIN A | reporter.nih.gov |
| Genetic Engineering of Vein Bypass Grafts in Vascular and Cardiovascular Surgery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,596,063 | February 1, 2007 | December 31, 2024 | LOGERFO, FRANK W | reporter.nih.gov |
| Inhibition of hepatic (V)LDL production by a novel antagonist of carboxyl esterase 1 | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,594,367 | September 1, 2023 | August 31, 2027 | DUNCAN, STEPHEN A | reporter.nih.gov |
| Integrated epidemiology of systemic and plaque-specific immunologic features of human atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,584,166 | August 1, 2024 | May 31, 2028 | FEINSTEIN, MATTHEW JOEL | reporter.nih.gov |
| Foam cells as drug targets in tuberculosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,575,009 | August 1, 2019 | June 30, 2025 | GENNARO, MARIA LAURA | reporter.nih.gov |
| Nutrition, Obesity and Atherosclerosis Training Program | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,574,347 | July 1, 1975 | June 30, 2028 | BORNFELDT, KARIN E | reporter.nih.gov |
| Molecular control of ischemia-induced tissue fibrosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,573,551 | July 1, 2020 | June 30, 2025 | YU, JUN | reporter.nih.gov |
| Macrophage Inflammarafts and Mitochondrial Dysfunction in Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,571,556 | February 1, 2024 | January 31, 2028 | MILLER, YURY | reporter.nih.gov |
| An Information tecHnology approach to implEmenting depression treAtment in caRdiac patienTs: [iHeart Trial] | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,570,899 | April 1, 2018 | March 31, 2025 | MOISE, NATHALIE | reporter.nih.gov |
| Role of SuPAR in the Intersection between Cardiovascular and Kidney Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,570,137 | July 1, 2020 | February 29, 2024 | HAYEK, SALIM | reporter.nih.gov |
| Anti-Atherogenic Mechanisms of Drebrin | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,569,750 | December 16, 2019 | June 30, 2024 | STIBER, JONATHAN A | reporter.nih.gov |
| Nutrition, terminal NAD metabolites and cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,568,658 | June 1, 2024 | April 30, 2028 | HAZEN, STANLEY L | reporter.nih.gov |
| Novel mechanisms for the generation of resolving monocytes | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,563,264 | April 1, 2022 | March 31, 2027 | LI, LIWU | reporter.nih.gov |
| Transcriptomics of adherent endothelial cells for improved endothelialization of small-diameter vascular grafts | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,563,058 | January 1, 2022 | December 30, 2026 | TEFFT, BRANDON J | reporter.nih.gov |
| The role of shear induced endothelial ZBTB46 in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,560,000 | July 1, 2020 | June 30, 2025 | REZVAN, AMIR | reporter.nih.gov |
| The methyltransferase Smyd1 regulates cardiac physiology | NIH | National Heart, Lung, and Blood Institute | 2022 to 2025 | $1,558,425 | July 15, 2022 | June 30, 2027 | FRANKLIN, SARAH | reporter.nih.gov |
| Air Pollution, Coronary Events and Atherosclerotic Progression in a Susceptible Population | NIH | National Institute of Environmental Health Sciences | 2021 to 2025 | $1,558,412 | July 21, 2021 | April 30, 2027 | WANG, MENG | reporter.nih.gov |
| Immune mechanisms of influenzaâÂÂinduced exacerbation of atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,558,220 | August 15, 2020 | July 31, 2025 | GOPAL, RADHA | reporter.nih.gov |
| Familial hypercholesterolemia screening in children: population impact of phenotype, genotype, and cascade approaches | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,555,215 | May 1, 2019 | April 30, 2025 | MORAN, ANDREW EDWARD | reporter.nih.gov |
| ApoE receptor-2 in vascular disease progression and regression | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,551,783 | April 1, 2019 | March 31, 2024 | HUI, DAVID YIU-KWAN | reporter.nih.gov |
| Function and Regulation of TSPAN2 in Vascular Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,548,375 | January 8, 2020 | December 31, 2025 | LONG, XIAOCHUN | reporter.nih.gov |
| Application of Machine Learning to Identify Obstructive Sleep Apnea Subgroups at Risk for Atherosclerosis Progression and Cardiovascular Disease Events (OSA-GRANDE) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,548,234 | March 1, 2024 | December 31, 2027 | SHAH, NEOMI A | reporter.nih.gov |
| IDOL and dyslipidemia in cardiovascular diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,547,876 | September 1, 2019 | July 31, 2024 | CHEN, YUQING EUGENE | reporter.nih.gov |
| Calciprotein Particles and Vascular Calcification in Patients with Chronic Kidney Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,540,142 | January 1, 2024 | December 31, 2028 | CHEN, WEI | reporter.nih.gov |
| The Function of Mammalian LPGAT1 | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,539,430 | February 10, 2023 | January 31, 2027 | SCHLAME, MICHAEL | reporter.nih.gov |
| Intravascular NIRF-IVUS imaging of inflammation-guided arterial therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,538,825 | March 17, 2020 | February 28, 2025 | JAFFER, FAROUC AMIN | reporter.nih.gov |
| IL1beta signaling in SMCpromotes beneficial changes in late stage atherosclerotic lesion pathogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,537,348 | February 1, 2019 | January 31, 2024 | OWENS, GARY K | reporter.nih.gov |
| Netrin-1 and Netrin-1 Preconditioned EPCs in Vascular Protection | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,531,810 | April 1, 2020 | January 31, 2026 | CAI, HUA LINDA | reporter.nih.gov |
| Contribution of novel lysoplasmalogenases enzymes in regulating macrophage immunometabolic responses in cardiovascular disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,531,119 | June 1, 2024 | April 30, 2028 | FERNANDEZ HERNANDO, CARLOS | reporter.nih.gov |
| Vascular-targeted Atheroprotective Gene therapies to Prevent Vein Graft Failure | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,529,131 | May 25, 2024 | February 28, 2028 | FERRAN, CHRISTIANE | reporter.nih.gov |
| Measurement and Reduction of Low-Value Cardiovascular Care | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,526,692 | April 1, 2024 | February 28, 2029 | KINI, VINAY | reporter.nih.gov |
| Regulation of Endothelial Lipase and HDL Metabolism by ANGPTL3 | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $1,525,416 | January 13, 2023 | December 31, 2027 | DAVIES, BRANDON SCOTT JOSEPH | reporter.nih.gov |
| Mitochondrial DNA heteroplasmy and risk for atherosclerotic cardiovascular disease (ASCVD) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,524,710 | August 5, 2019 | July 31, 2024 | ARKING, DAN E | reporter.nih.gov |
| Cu uptake transporter as a disturbed flow sensor in vascular inflammatory disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,524,600 | April 1, 2024 | March 31, 2028 | FUKAI, TOHRU | reporter.nih.gov |
| The role of immune-responsive gene 1 and itaconate in atherosclerotic disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,515,890 | April 1, 2024 | March 31, 2028 | MOORE, KATHRYN J | reporter.nih.gov |
| Nef in impaired efferocytosis: a novel mechanism for vascular disease in HIV | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,511,729 | September 1, 2024 | August 31, 2028 | AIKAWA, MASANORI | reporter.nih.gov |
| EHR Nudges: Optimizing a Clinical Decision Support System for Evidence-Based Statin Medication Prescribing to Reduce the Risk of Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,509,111 | January 1, 2024 | December 31, 2028 | RICHARDSON, SAFIYA | reporter.nih.gov |
| Mechanisms regulating the atherogenic activities of serum amyloid A | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,504,731 | July 5, 2020 | June 30, 2025 | SHRIDAS, PREETHA | reporter.nih.gov |
| RNA-Mediated Inter-Organelle Communication in Atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,496,553 | July 1, 2020 | June 30, 2025 | ARDITI, MOSHE | reporter.nih.gov |
| Vascular macrophages and T cells in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,496,145 | March 18, 2019 | July 31, 2022 | LEY, KLAUS F. | reporter.nih.gov |
| Leptin in HIV associated vascular diseases | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,495,092 | January 1, 2020 | December 31, 2024 | BELIN DE CHANTEMELE, ERIC J | reporter.nih.gov |
| The molecular basis for the role of apolipoprotein A-II in cholesterol and triglyceride metabolism | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,491,965 | December 15, 2020 | November 30, 2025 | DAVIDSON, W SEAN | reporter.nih.gov |
| Noninvasive Testing of Coronary Microvascular Reactivity Using High-resolution Free-breathing MRI | NIH | National Heart, Lung, and Blood Institute | 2022 to 2024 | $1,489,262 | July 15, 2020 | November 1, 2024 | SHARIF, BEHZAD | reporter.nih.gov |
| Multi-Ethnic Study of Atherosclerosis- Cellular Exosomes in Neurodegeneration and Dementia (MESA-CEND) | NIH | National Institute on Aging | 2024 to 2025 | $1,486,033 | August 15, 2021 | July 31, 2026 | DEEP, GAGAN | reporter.nih.gov |
| Systems genetics approach to inflammatory mechanisms in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,485,800 | July 12, 2019 | May 31, 2024 | LUSIS, ALDONS JAKE | reporter.nih.gov |
| Impact of L. plantarum 299v Supplementation on Endothelial Function and Systemic Inflammation | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,482,252 | March 22, 2019 | January 31, 2025 | WIDLANSKY, MICHAEL E | reporter.nih.gov |
| Personalized Statin Treatment Plan to Optimize Clinical Outcomes Using Big Data | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,481,960 | February 15, 2019 | January 31, 2025 | CHI, CHIH-LIN | reporter.nih.gov |
| Biphasic Regulation of Endothelial Transdifferentiation by Alcohol and Its Impact on Vascular Disease | NIH | National Institute on Alcohol Abuse and Alcoholism | 2023 to 2025 | $1,481,378 | September 20, 2023 | August 31, 2028 | REDMOND, EILEEN M. | reporter.nih.gov |
| Novel methodologies to improve coronary artery disease diagnostics with dynamic PET | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,476,019 | July 1, 2024 | June 30, 2029 | TANG, JING | reporter.nih.gov |
| CCDC92 and Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2023 to 2024 | $1,472,666 | January 1, 2023 | December 31, 2026 | FAN, YANBO | reporter.nih.gov |
| RNA binding proteins in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,471,296 | April 1, 2018 | January 31, 2029 | SALLAM, TAMER | reporter.nih.gov |
| Per- and polyfluoroalkyl substances, apolipoproteins, and risk of coronary heart disease | NIH | National Institute of Environmental Health Sciences | 2024 to 2025 | $1,468,436 | April 16, 2024 | January 31, 2029 | SUN, QI | reporter.nih.gov |
| Long noncoding RNA regulation of Atherosclerotic Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,463,686 | March 15, 2024 | February 28, 2028 | MOORE, KATHRYN J | reporter.nih.gov |
| Molecular Mechanisms of Flow-dependent Arterial Remodeling in Peripheral Arterial Disease | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,463,377 | August 1, 2018 | July 31, 2024 | BREWSTER, LUKE PACKARD | reporter.nih.gov |
| Cardiac photon counting CT and its application in studying interactions between Alzheimer's and heart disease | NIH | National Institute on Aging | 2024 to 2025 | $1,460,965 | February 15, 2021 | May 31, 2026 | BADEA, CRISTIAN T | reporter.nih.gov |
| The structural basis for cholesterol esterification in human plasma | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,459,708 | September 1, 2020 | July 31, 2025 | DAVIDSON, W SEAN | reporter.nih.gov |
| Lipoprotein (a) Modification of the Impact of HIV Infection on Atherosclerotic Cardiovascular Disease | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,456,267 | September 1, 2024 | August 31, 2029 | LEUCKER, THORSTEN M | reporter.nih.gov |
| Advancing Endovascular PAD Treatment: Overcoming Critical Knowledge Gaps with MRI-histology | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,453,551 | July 1, 2024 | April 30, 2029 | ROY, TRISHA | reporter.nih.gov |
| The Matricellular Protein Cyr61 Signaling Axis in Arterial Restenosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,452,594 | July 1, 2020 | June 30, 2025 | CUI, MEI-ZHEN | reporter.nih.gov |
| Development and Translation of Generator-Produced PET Tracer for Myocardial Perfusion Imaging | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,450,088 | March 1, 2019 | February 28, 2025 | SHARMA, VIJAY | reporter.nih.gov |
| MECHANISMS UNDERLYING THE AGE-RELATED ATHEROPROTECTIVE EFFECTS OF HORMONE THERAPY | NIH | National Institute on Aging | 2021 to 2022 | $1,448,054 | August 1, 2018 | April 30, 2025 | HODIS, HOWARD NEIL | reporter.nih.gov |
| Effect of sphingomyelin biosynthesis on atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,444,863 | January 1, 2020 | December 31, 2024 | JIANG, XIAN-CHENG | reporter.nih.gov |
| Transcutaneous ARFI Ultrasound for Differentiating Carotid Plaque with High Stroke Risk | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,444,031 | August 1, 2009 | November 30, 2023 | GALLIPPI, CATERINA M | reporter.nih.gov |
| Effect of PCSK9 Inhibition on Cardiovascular Risk in Treated HIV Infection (EPIC-HIV Study) | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,442,594 | February 1, 2018 | January 31, 2024 | HSUE, PRISCILLA Y. | reporter.nih.gov |
| Novel pathways controlling macrophage inflammation and resolution in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,441,962 | August 1, 2019 | July 31, 2024 | HOTAMISLIGIL, GOKHAN S | reporter.nih.gov |
| Atheroprotective Gene Therapy | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,440,870 | June 10, 2013 | November 30, 2024 | DICHEK, DAVID A | reporter.nih.gov |
| JHS TRAINING AND EDUCATION CENTER NHLBI FUNDING 9/15/2025 - 9/14/2026 | NIH | National Heart, Lung, and Blood Institute | 2025 | $1,439,525 | September 15, 2025 | September 14, 2026 | SRINIVASAN, ASOKA S | reporter.nih.gov |
| Targeted suppression of ALDH1A3 for endothelial beneficial management of restenosis after vascular surgery | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,439,252 | August 26, 2024 | May 31, 2028 | GUO, LIANWANG | reporter.nih.gov |
| ApoA1 lipidation by ABCA1 in HDL biogenesis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,438,368 | April 1, 2016 | June 30, 2025 | SMITH, JONATHAN D | reporter.nih.gov |
| EphA2 regulation of atherosclerotic smooth muscle phenotype | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,438,100 | July 1, 2024 | May 31, 2028 | ORR, ANTHONY WAYNE | reporter.nih.gov |
| A paradigm for comprehensive genetic association studies of complex disease using pangenomic methods and local ancestry inference | NIH | National Human Genome Research Institute | 2024 to 2025 | $1,437,777 | January 15, 2024 | December 31, 2027 | HALL, IRA M | reporter.nih.gov |
| Targeted editing of ASGR1 for cardiovascular diseases | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,429,675 | March 15, 2024 | February 28, 2028 | HAN, RENZHI | reporter.nih.gov |
| Sudden cardiac arrest and circulating hydrogen sulfide | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,428,872 | May 1, 2019 | April 30, 2025 | TOTAH, RHEEM ANGELA | reporter.nih.gov |
| In vivo insights of small vessel changes with age using USPIO-enhanced MRI | NIH | National Institute of Neurological Disorders and Stroke | 2021 to 2022 | $1,427,279 | September 15, 2018 | June 30, 2025 | GE, YULIN | reporter.nih.gov |
| Glucose homeostasis and the risk of Alzheimer's disease and Alzheimer's disease related dementias in the Multi-Ethnic Study of Atherosclerosis | NIH | National Institute on Aging | 2024 to 2025 | $1,426,783 | September 30, 2021 | August 31, 2027 | MONGRAW-CHAFFIN, MORGANA LEE | reporter.nih.gov |
| Novel Incidental Calcium Evaluation (NICE) | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,419,338 | July 1, 2024 | April 30, 2028 | RODRIGUEZ, FATIMA | reporter.nih.gov |
| Protein Arginine Methylation in Vascular Smooth Muscle Cell Phenotypic Modulation and Calcification | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,419,176 | August 1, 2023 | June 30, 2027 | CHEN, YABING | reporter.nih.gov |
| APOM deficiency contributes to renal failure in glomerular diseases | NIH | National Institute of Diabetes and Digestive and Kidney Diseases | 2023 to 2025 | $1,415,462 | July 1, 2023 | April 30, 2027 | FORNONI, ALESSIA | reporter.nih.gov |
| IL17RC signaling as a regulator of host- microbiota interactions and aortic neuroinflammation in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,403,732 | April 1, 2024 | February 29, 2028 | KOLTSOVA, EKATERINA | reporter.nih.gov |
| Echogenic Targeted Liposomes: Transfection/Drug Delivery | NIH | National Heart, Lung, and Blood Institute | 2021 to 2025 | $1,402,657 | April 15, 2017 | May 31, 2029 | MCPHERSON, DAVID D | reporter.nih.gov |
| A lipid-induced RNA-binding protein in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,401,825 | April 1, 2020 | March 31, 2025 | DIMAYUGA, PAUL C. | reporter.nih.gov |
| The Genetic and Molecular Basis of Cholesterol Efflux | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $1,399,758 | December 15, 2017 | November 30, 2024 | ROHATGI, ANAND KUMAR | reporter.nih.gov |
Organizations
| Organization | Place | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|---|
| Columbia University Health Sciences | New York, NY | 43 | $84.4 million | 0 | $0 |
| Massachusetts General Hospital | Boston, MA | 37 | $61 million | 0 | $0 |
| University of Washington | Seattle, WA | 26 | $58.7 million | 0 | $0 |
| New York University School of Medicine | New York, NY | 27 | $54.2 million | 0 | $0 |
| Yale University | New Haven, CT | 35 | $51.8 million | 0 | $0 |
| University of California Los Angeles | Los Angeles, CA | 31 | $46.1 million | 0 | $0 |
| Wake Forest University Health Sciences | Winston-Salem, NC | 17 | $44.3 million | 0 | $0 |
| University of Mississippi Med CTR | Jackson, MS | 7 | $42.5 million | 0 | $0 |
| Vanderbilt University Medical Center | Nashville, TN | 29 | $42.2 million | 0 | $0 |
| Stanford University | Stanford, CA | 37 | $41.8 million | 0 | $0 |
| University of Virginia | Charlottesville, VA | 28 | $38.4 million | 0 | $0 |
| Duke University | Durham, NC | 24 | $38.2 million | 0 | $0 |
| Brigham and Women's Hospital | Boston, MA | 35 | $36.3 million | 0 | $0 |
| University of California, San Francisco | San Francisco, CA | 20 | $34.5 million | 0 | $0 |
| Univ of North Carolina Chapel Hill | Chapel Hill, NC | 20 | $33.9 million | 0 | $0 |
| Cedars-Sinai Medical Center | Los Angeles, CA | 17 | $33.6 million | 0 | $0 |
| Icahn School of Medicine at Mount Sinai | New York, NY | 20 | $32.1 million | 0 | $0 |
| University of Pittsburgh at Pittsburgh | Pittsburgh, PA | 22 | $30.4 million | 0 | $0 |
| University of Florida | Gainesville, FL | 4 | $29.7 million | 0 | $0 |
| Augusta University | Augusta, GA | 19 | $28.2 million | 0 | $0 |
| University of Southern California | Los Angeles, CA | 12 | $28.1 million | 0 | $0 |
| Johns Hopkins University | Baltimore, MD | 26 | $27.9 million | 0 | $0 |
| Weill Medical Coll of Cornell Univ | New York, NY | 20 | $27.5 million | 0 | $0 |
| University of California, San Diego | La Jolla, CA | 17 | $24.3 million | 0 | $0 |
| Northwestern University at Chicago | Chicago, IL | 12 | $22.5 million | 0 | $0 |
| Boston Children's Hospital | Boston, MA | 10 | $21.4 million | 0 | $0 |
| Medical College of Wisconsin | Milwaukee, WI | 20 | $21.4 million | 0 | $0 |
| University of Michigan at Ann Arbor | Ann Arbor, MI | 18 | $21 million | 0 | $0 |
| Mayo Clinic Jacksonville | Jacksonville, FL | 2 | $19.9 million | 0 | $0 |
| Emory University | Atlanta, GA | 17 | $19.9 million | 0 | $0 |
| University of Minnesota | Minneapolis, MN | 14 | $19.7 million | 0 | $0 |
| University of Alabama at Birmingham | Birmingham, AL | 14 | $18.9 million | 0 | $0 |
| Ut Southwestern Medical Center | Dallas, TX | 20 | $18.1 million | 0 | $0 |
| University of Utah | Salt Lake City, UT | 11 | $17.3 million | 0 | $0 |
| Washington University | Saint Louis, MO | 13 | $16.7 million | 0 | $0 |
| New York University D/b/a NYU Long Island School of Medicine | Mineola, NY | 7 | $16.3 million | 0 | $0 |
| University of Cincinnati | Cincinnati, OH | 13 | $15.9 million | 0 | $0 |
| University of Illinois at Chicago | Chicago, IL | 7 | $15.7 million | 0 | $0 |
| University of Chicago | Chicago, IL | 12 | $15.1 million | 0 | $0 |
| Louisiana State Univ HSC Shreveport | Shreveport, LA | 14 | $15 million | 0 | $0 |
| University of Arizona | Tucson, AZ | 11 | $13.6 million | 0 | $0 |
| Cleveland Clinic Lerner Com-Cwru | Cleveland, OH | 11 | $13.6 million | 0 | $0 |
| Chapman University | Orange, CA | 1 | $12.7 million | 0 | $0 |
| University of Pennsylvania | Philadelphia, PA | 15 | $11.9 million | 0 | $0 |
| Case Western Reserve University | Cleveland, OH | 11 | $11.7 million | 0 | $0 |
| Tulane University of Louisiana | New Orleans, LA | 6 | $11.1 million | 0 | $0 |
| University of Iowa | Iowa City, IA | 7 | $10.7 million | 0 | $0 |
| Oregon Health & Science University | Portland, OR | 8 | $10.5 million | 0 | $0 |
| Boston University Medical Campus | Boston, MA | 7 | $10.3 million | 0 | $0 |
| Albert Einstein College of Medicine | Bronx, NY | 8 | $10.1 million | 0 | $0 |
| Mayo Clinic Rochester | Rochester, MN | 8 | $9.6 million | 0 | $0 |
| University of Miami School of Medicine | Coral Gables, FL | 10 | $9.3 million | 0 | $0 |
| Joslin Diabetes Center | Boston, MA | 4 | $9.1 million | 0 | $0 |
| Temple Univ of the Commonwealth | Philadelphia, PA | 10 | $8.7 million | 0 | $0 |
| University of Louisville | Louisville, KY | 5 | $8.7 million | 0 | $0 |
| Northwestern University | Chicago, IL | 4 | $8.2 million | 0 | $0 |
| Beth Israel Deaconess Medical Center | Boston, MA | 7 | $8.2 million | 0 | $0 |
| University of Maryland Baltimore | Baltimore, MD | 6 | $8.1 million | 0 | $0 |
| University of Texas HLTH Sci CTR Houston | Houston, TX | 4 | $7.9 million | 0 | $0 |
| University of California at Davis | Davis, CA | 5 | $7.7 million | 0 | $0 |
| University of California-Irvine | Irvine, CA | 7 | $7.7 million | 0 | $0 |
| Ohio State University | Columbus, OH | 6 | $7.2 million | 0 | $0 |
| Cincinnati Childrens Hosp Med CTR | Cincinnati, OH | 3 | $7.2 million | 0 | $0 |
| SUNY at Buffalo | Amherst, NY | 8 | $7.1 million | 0 | $0 |
| Baylor College of Medicine | Houston, TX | 6 | $7 million | 0 | $0 |
| Drexel University | Philadelphia, PA | 3 | $7 million | 0 | $0 |
| University of Kentucky | Lexington, KY | 8 | $6.8 million | 0 | $0 |
| University of Wisconsin-Madison | Madison, WI | 5 | $6.6 million | 0 | $0 |
| Tougaloo College | Tougaloo, MS | 2 | $6.6 million | 0 | $0 |
| Scripps Research Institute, the | La Jolla, CA | 2 | $6 million | 0 | $0 |
| Albany Medical College | Albany, NY | 6 | $6 million | 0 | $0 |
| Brown University | Providence, RI | 4 | $6 million | 0 | $0 |
| Geisinger Clinic | Danville, PA | 2 | $5.9 million | 0 | $0 |
| Lurie Children's Hospital of Chicago | Chicago, IL | 2 | $5.8 million | 0 | $0 |
| Research Inst Nationwide Children's Hosp | Columbus, OH | 4 | $5.7 million | 0 | $0 |
| University of California-Riverside | Riverside, CA | 3 | $5.4 million | 0 | $0 |
| University of Rochester | Rochester, NY | 7 | $5.4 million | 0 | $0 |
| Methodist Hospital Research Institute | Houston, TX | 4 | $5.3 million | 0 | $0 |
| Harvard University D/b/a Harvard School of Public Health | Boston, MA | 5 | $5.1 million | 0 | $0 |
| Jackson State University | Jackson, MS | 2 | $5.1 million | 0 | $0 |
| Georgia Tech Research Corporation | Atlanta, GA | 2 | $4.8 million | 0 | $0 |
| University of Missouri-Columbia | Columbia, MO | 4 | $4.5 million | 0 | $0 |
| University of Connecticut SCH of Med/dnt | Farmington, CT | 5 | $4.5 million | 0 | $0 |
| Kaiser Foundation Research Institute | Oakland, CA | 2 | $4.2 million | 0 | $0 |
| Crossliner INC | Kalamazoo, MI | 1 | $3.8 million | 0 | $0 |
| University of Illinois at Urbana-Champaign | Urbana, IL | 3 | $3.8 million | 0 | $0 |
| Univ of Massachusetts Med SCH Worcester | Worcester, MA | 4 | $3.7 million | 0 | $0 |
| University of Colorado Denver | Aurora, CO | 3 | $3.6 million | 0 | $0 |
| Indiana University Indianapolis | Indianapolis, IN | 4 | $3.5 million | 0 | $0 |
| Mississippi State Department of Health | Jackson, MS | 1 | $3.3 million | 0 | $0 |
| Wayne State University | Detroit, MI | 4 | $3.2 million | 0 | $0 |
| Georgia State University | Atlanta, GA | 4 | $3.2 million | 0 | $0 |
| Cornell University | Ithaca, NY | 2 | $3.1 million | 0 | $0 |
| Pennsylvania State Univ Hershey Med CTR | Hershey, PA | 3 | $3 million | 0 | $0 |
| Tufts University Boston | Boston, MA | 5 | $3 million | 0 | $0 |
| Massachusetts Institute of Technology | Cambridge, MA | 2 | $2.9 million | 0 | $0 |
| Northeast Ohio Medical University | Rootstown, OH | 5 | $2.8 million | 0 | $0 |
| Tufts Medical Center | Boston, MA | 2 | $2.7 million | 0 | $0 |
| Clemson University | Clemson, SC | 4 | $2.7 million | 0 | $0 |
| Virginia Commonwealth University | Richmond, VA | 3 | $2.7 million | 0 | $0 |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2025 | 547 | $351,496,345 | 0 | $0 |
| 2024 | 578 | $345,748,474 | 0 | $0 |
| 2023 | 595 | $374,551,701 | 0 | $0 |
| 2022 | 633 | $354,190,202 | 0 | $0 |
| 2021 | 615 | $362,473,449 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
Updated November 3, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-02). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.